These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2004-000149-39 'Phase III Randomized Trial to Evaluate the Efficacy and Safety of Second-line Therapy with Fludara plus Alentuzumab (CAMPATH, MabCampth) versus Fludara Alone in patients with B-Cell Chronic Lymphocyt... 2010-06-18 due-trials
Listed as ongoing, but also has a completion date and reported results 2004-000555-42 A randomized, double-blind, placebo-controlled, parallel group design study to evaluate the efficacy and safety of teriflunomide (HMR1726D) in reducing the frequency of relapses and delaying the accum... 2010-09-01 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-000572-14 Phase II multicenter, open label, non-randomized study of intravenous RPR109881 q 3 weeks in patients with metastatic breast cancer progressing after therapy with anthracyclines, taxanes, and capecita... 2009-04-17 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-000616-70 Efficacy and safety of insulin glulisine compared with insulin lispro in children and adolescents with type 1 diabetes mellitus: a 26-week, multicenter, open, parallel clinical trial 2007-02-05 bad-data
Ongoing 2004-000618-38 A randomized, open-label, phase III study of RPR109881 IV every 3 weeks versus capecitabine (Xeloda®) tablets twice daily for 2 weeks in 3-week cycles in patients with metastatic breast cancer progres... not-yet-due
Reported results 2004-000738-34 Multinational, randomized, double-blind, double-dummy, comparative study to evaluate the efficacy and safety of telithromycin 25 mg/kg given once daily for 5 or 10 days depending on age and previous t... 2007-09-03 due-trials
Ongoing, reported early 2004-000763-98 A phase II, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of HP184 at 100, 200 and 400 mg doses administered orally once daily for twenty-four weeks in adult su... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2004-000822-58 A double blind randomized study of Clopidogrel 75 mg/d versus placebo on a background of ASA 75-100 mg/d, in peripheral arterial disease (PAD) patients receiving a unilateral below knee by-pass graft 2006-08-28 bad-data
Ongoing, reported early 2004-000851-41 A randomized, double-blind, placebo-controlled, parallel-group, fixed-dose, multicenter study evaluating the efficacy and safety of four doses of SR147778 in obese patients not-yet-due
Ongoing, reported early 2004-000904-41 A multinational, randomized, double-blind, double-dummy, exploratory, parallel-group, dose-ranging phase II study to evaluate the pharmacodynamics, the safety and tolerability, and the pharmacokinetic... not-yet-due
Completed, but no date, and reported results 2004-001044-72 Randomized phase II trial of two sequential schedules of docetaxel and cisplatin followed by gemcitabine in patients with advanced non-small-cell lung cancer. bad-data
Listed as ongoing, but also has a completion date and reported results 2004-001287-49 52-week, open, randomized, multinational, multicenter clinical trial comparing insulin glulisine in combination with insulin glargine in an intensified insulin regimen to a two-injection conventional ... 2008-01-01 bad-data
Ongoing, reported early 2004-001330-16 Estudio de Fase II, aleatorizado, multicéntrico, doble ciego y controlado con placebo, del efecto de SR57667B sobre la función dopaminérgica nigro-estriada, evaluado mediante imágenes PET 18F-Dopa en ... not-yet-due
Reported results 2004-001412-30 An open-label, randomized, multicenter, clinical study to compare the effects of telithromycin, azithromycin and cefuroxime axetil on the penicillin or macrolide resistance of Streptococcus pneumoniae... 2006-05-20 due-trials
Listed as ongoing, but also has a completion date and reported results 2004-001677-26 Nolpitantium Besylate in patients with mild to moderate Ulcerative Colitis a double-blind, placebo controlled efficacy and safety, 8-week study 2006-09-21 bad-data
Ongoing, reported early 2004-001682-17 A Randomized Dose Ranging Study of Hexadecasaccharide including Active Control, in Patients with Unstable Angina or Non-ST-segment Elevation Myocardial Infarction Scheduled to Undergo Percutaneous Cor... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2004-001766-40 Placebo controlled double blind dose ranging study of the efficacy and safety of SSR149744C 50, 100, 200 or 300 mg OD, with amiodarone as calibrator for the maintenance of sinus rhythm in patients wit... 2006-05-11 bad-data
Ongoing, reported early 2004-001841-14 Dose-ranging pharmacodynamic assessment of platelet aggregation inhibition with clopidogrel in children of Blalock-Taussig shunt age categories (neonates and infants/toddlers) not-yet-due
Completed, but no date, and reported results 2004-001967-24 Kiegészítő zolpidem kezelés friss antidepresszáns kezelés alatt álló disztimiás vagy depressziós betegek alvászavarának kezelésében bad-data
Listed as ongoing, but also has a completion date and reported results 2004-002017-37 Phase III randomized trial of concomitant radiation, cisplatin, and tirapazamine (SR259075) versus concomitant radiation and cisplatin in patients with advanced head and neck cancer 2008-01-16 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-002036-25 Comparison of three therapeutic strategies for treating type 2 diabetes mellitus patients poorly controlled with basal insulin associated with oral antidiabetic drugs. 2008-12-01 bad-data
Completed, but no date, and reported results 2004-002168-59 An Open-Label, Multicenter, Multinational, Study of the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Acid alpha- Glucosidase (rhGAA) Treatment in Patients > 6 and <= 3... bad-data
Completed, but no date, and reported results 2004-002173-23 PHASE 2 CLINICAL STUDY PROTOCOL: SAFETY AND EFFICACY OF RISING DOSES OF DEFERITRIN IN BETA-THALASSEMIA PATIENTS bad-data
Listed as ongoing, but also has a completion date and reported results 2004-002174-32 An Open Label, Randomized, Parallel Design Study to Investigate the Efficacy and Safety of Sevelamer Hydrochloride Renagel Compared with Calcium Acetate in Peritoneal Dialysis Patients 2006-04-27 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-002203-32 A Multicenter, Open-Label, Randomized, Phase III Trial Comparing Immediate Adjuvant Hormonal Therapy (ELIGARD®- leuprolide acetate) in Combination with TAXOTERE® (docetaxel) Administered Every Three W... 2010-12-17 bad-data
Reported results 2004-002317-37 OPEN-LABEL STUDY TO DETERMINE HOW PRIOR THERAPY WITH ALENDRONATE OR RISEDRONATE IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS INFLUENCES THE CLINICAL EFFECTIVENESS OF TERIPARATIDE 2007-04-17 due-trials
Ongoing, reported early 2004-002327-41 an eight-week, multicenter, double-blind, placebo-controlled study evaluating the efficacy, safety and tolerability of one fixed 100 mg dose of Saredutant in patients with Major Depressive Disorder not-yet-due
Listed as ongoing, but also has a completion date and reported results 2004-002328-16 An eight-week, multicenter, double-blind, placebo-controlled study evaluating the efficacy, safety and tolerability of one fixed 100 mg dose of Saredutant in patients with Major Depressive Disorder 2006-12-26 bad-data
Ongoing, reported early 2004-002349-11 A randomisation, double-blind, placebo-controlled, parallel-group, multicenter study evaluating the efficacy and safety of SR121463B in patients with syndrome of inappropriate antidiuretic hormone sec... not-yet-due
Completed, but no date, and reported results 2004-002390-23 Evaluation of the pharmacokinetic profile of Riluzole (XRP4274) and RPR112512 following multiple oral administrations of XRP4274 for 8 days in healthy Japanese and Caucasian male subjects bad-data
Listed as ongoing, but also has a completion date and reported results 2004-002397-38 12-week, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy, pharmacodynamic and safety of two doses of alfuzosin (0.1 mg/kg/day; 0.2 mg/kg/day... 2009-12-16 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-002508-13 A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter, Dose-Selection Study of Ad2/Hypoxia Inducible Factor HIF-1alfa/VP16 in Patients with Intermittent Claudication. 2010-03-11 bad-data
Completed, but no date, and reported results 2004-002729-34 PILOT STUDY FOR THE EVALUATION OF THE EFFECTS OF INSULIN TREATMENT ON MYOCARDIAL FUNCTION, PERFUSION, AND GLUCOSE METABOLISM IN PATIENTS WITH PRIMARY LEFT VENTRICULAR DYSFUNCTION AND TYPE 2 DIABETES bad-data
Completed, but no date, and reported results 2004-002730-19 see above bad-data
Completed, but no date, and reported results 2004-002731-62 OPTIMISATION OF INSULIN TREATMENT OF TYPE 2 DIABETES MELLITUS BY TELECARE ASSISTANCE FOR SELF MONITORING OF BLOOD GLUCOSE ELEONOR STUDY bad-data
Completed, but no date, and reported results 2004-003809-25 Comparison of the efficacy and tolerability of drotaverine 80 mg or ibuprofen 400 mg administered alone with their combination for the treatment of primary and secondary dysmenorrhea bad-data
Ongoing, reported early 2004-003885-14 Multidisciplinar, multicenter, randomized phase III clinical trial comparing taxotere plus estramustine phosphate plus prednisone, versus taxotere prednisone, in advanced prostate carcinoma patients w... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2004-003929-27 Randomized, multicenter, double-blind, placebo-controlled, two-arm parallel group trial of rimonabant 20-mg od, for inhibition of astherosclerosis progression assessed by IVUS (IntraVascular UltraSoun... 2007-10-11 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-003985-14 A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial Evaluating the Effect of a Vasopressin V2 Receptor Antagonist (SR121463B) on Serum Sodium in Patients with Dilutional Hyponatremia 2007-07-18 bad-data
Completed, but no date, and reported results 2004-004461-15 SOLIAN solution in the acute setting bad-data
Listed as ongoing, but also has a completion date and reported results 2004-004676-37 A randomized, double-blind study of GT267-004 versus vancomycin, and GT267-004 versus metronidazole, in patients with C.difficile-associated diarrhea 2007-08-08 bad-data
Reported results 2004-004799-35 Double blind placebo controlled dose ranging study of the efficacy and safety of SSR149744C 100 or 300 mg for the prevention of ventricular arrhythmia-triggered ICD interventions 2007-02-23 due-trials
Listed as ongoing, but also has a completion date and reported results 2004-004881-34 A randomized, double-blind, placebo-controlled, parallel-group, fixed-dose (rimonabant 20mg) multicenter study of long-term glycemic control with rimonabant in treatment-naïve patients with type 2 dia... 2006-06-09 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-005239-25 An open-label, multicenter study evaluating the long-term safety and efficacy of SR121463B in patients with Syndrome of Inappropriate Antidiuretic Hormone Secretion. 2007-08-28 bad-data
Ongoing, reported early 2004-005261-38 A Multicenter, Parallel, Double-Blind, Blinded Evaluator, Randomized Comparison of the Efficacy and Safety of an Alternate Viscosupplement (AVS-beta) to Methylprednisolone Acetate in Patients with Sym... not-yet-due
Ongoing, reported early 2005-000577-21 Estudio abierto y multicéntrico, de cincuenta y dos semanas de duración, para evaluar la seguridad y tolerabilidad a largo plazo de SR58611A 350 mg cada 12 horas en pacientes con trastorno depresivo ... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2005-000715-98 A placebo-controlled, double-blind, parallel arm Trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular Hospitalization or death from any cause in patients with At... 2008-04-21 bad-data
Reported results 2005-000807-33 A randomized, double blind, two-arms placebo-controlled, parallel group, multicenter study of rimonabant 20 mg once daily in the treatment of atherogenic dyslipidemia in abdominally obese patients 2007-04-19 due-trials
Reported results 2005-000823-40 Double blind placebo controlled dose ranging study of the efficacy and safety of SSR149744C 300 or 600 mg for the conversion of atrial fibrillation/flutter 2006-04-21 due-trials
Reported results 2005-000959-15 A multicenter clinical trial to evaluate quality of life in patients with Type 2 diabetes before and after changing therapy to a combination of insulin glargine and oral antidiabetic drugs in a real l... 2008-06-26 due-trials
Reported results 2005-001612-49 Ensayo aleatorizado, multicéntrico, doble ciego, controlado con placebo y con dos grupos paralelos, de rimonabant 20 mg od, para la inhibición de la progresión de la aterosclerosis evaluada mediante e... 2009-04-27 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-001613-17 A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Fixed- Dose Study Evaluating the Effect of One Dose of Rimonabant 20 mg/day on Glycemic Control in Type 2 Diabetic Patien... 2007-07-30 bad-data
Reported results 2005-001629-27 A Long-term Continuation Study of Patients with Infantile-Onset Pompe Disease who were previously enrolled in Protocol AGLU01602 2006-06-12 due-trials
Ongoing, reported early 2005-001873-91 Docetaxel (Taxotere) v léčbě hormonálně independentního karcinomu prostaty. not-yet-due
Listed as ongoing, but also has a completion date and reported results 2005-002161-36 Randomized comparison of a two-month regimen of irbesartan versus enalapril on cardiovascular markers in patients with acute coronary syndrome without ST segment elevation. 2007-03-23 bad-data
Completed, but no date 2005-002175-32 Take evaluation and safety of smallpox vaccine (LISTER strain) in naïve healthy adults bad-data
Reported results 2005-002401-23 Immunogenicity of the Inactivated, Split-Virion Influenza Vaccine Administered by the Intradermal Route in Comparison with Intramuscular Vaccination with Vaxigrip® in Adults. 2008-07-02 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-002568-27 A randomized, double blind, two-arm placebo controlled, 12-Month study of the effects of rimonabant 20mg once daily on the amount and the activity of visceral fat in abdominally obese patients with me... 2008-07-24 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-002570-30 A multicenter randomized, double-blind placebo controlled phase III study of the efficacy of Xaliproden in preventing the neurotoxicity of oxaliplatin in first-line treatment of patients with metastat... 2009-10-30 bad-data
Ongoing, reported early 2005-002614-38 COMPARISON OF TWO THERAPEUTIC STRATEGIES FOR TREATING TYPE 2 DIABETIC PATIENTS POORLY CONTROLLED WITH BASAL INSULIN ASSOCIATED WITH ORAL ANTIDIABETIC DRUGS: 6-MONTH PROOF OF CONCEPT STUDY not-yet-due
Reported results 2005-002759-42 A Randomized, Double-Blind, Multicenter, Multinational, Placebo-Controlled Study of the Safety, Efficacy, and Pharmacokinetics of Myozyme, Recombinant Human Acid alpha-Glucosidase (rhGAA), Treatment i... 2007-08-29 due-trials
Ongoing, reported early 2005-002829-31 Full title of the trial : A Single Centre, Open-Label, Bridging Study of the Safety, Pharmacokinetics and Efficacy of Recombinant Human Acid Alpha-Glucosidase (rhGAA) Treatment in Patients with Late-O... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2005-002942-20 Ensayo aleatorizado, multinacional, multicéntrico, doble ciego, controlado con placebo, con dos grupos paralelos, de rimonabant 20 mg od, para la reducción del riesgo de acontecimientos cardiovascular... 2009-04-29 bad-data
Reported results 2005-002958-21 The determination of the exact time of administration of Lantus basal insulin for treating type 2 diabetes mellitus patients poorly controlled with basal insulin associated with oral antidiabetic drug... 2008-06-20 due-trials
Completed, but no date, and reported results 2005-002965-35 Safety of the Inactivated, Split-Virion Influenza Vaccine Administered by the Intradermal Route in Healthy Children bad-data
Listed as ongoing, but also has a completion date and reported results 2005-003080-23 Efficacy and safety of eplivanserin 5mg/day on sleep maintenance insomnia: a 12-week multicenter, randomized, double-blind, placebo-controlled study 2008-01-03 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-003082-16 Efficacy and safety of eplivanserin 5mg/day on Sleep Maintenance Insomnia : a 12-week multicenter, randomized, double-blind, placebo-controlled study followed by an open treatment phase extension wi... 2008-09-10 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-003119-62 Double-blind, double-dummy, randomized, parallel group trial of SL650472 (three dose regimens versus placebo and cilostazol), for 24-week improvement of walking distance in patients with stage II peri... 2008-12-03 bad-data
Completed, but no date, and reported results 2005-003180-23 An 8-week, double blind, placebo-controlled, multicenter study with paroxetine (20 mg q24) as positive control, evaluating the efficacy and safety of 2 fixed doses of SR58611A (175 mg q12 and 350 mg q... bad-data
Reported results 2005-003181-41 An eight-week, double-blind, placebo-controlled, multicenter study with paroxetine (20 mg q24) as positive control, evaluating the efficacy, safety and tolerability of a fixed dose of SR58611A (350 mg... 2007-01-18 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-003233-41 An open label, dose titration study of sevelamer carbonate tablets dosed three times a day in hyperphosphatemic chronic kidney disease patients not on dialysis 2007-03-31 bad-data
Reported results 2005-003258-87 Efficacy and safety of intra-articular multiple doses of 500 µg icatibant including 40 mg triamcinolone as calibrator in a randomized, double-blind, parallel-group, placebo-controlled 13-week multi-ce... 2007-07-31 due-trials
Ongoing, reported early 2005-003449-15 A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of ISIS 301012 as Add-on Therapy in Homozygous Familial Hypercholesterolemia Subjects not-yet-due
Ongoing, reported early 2005-003450-10 An Open-Label Extension Study to Assess the Long-Term Safety and Efficacy of ISIS 301012 in Patients with Familial Hypercholesterolemia or Severe Hypercholesterolemia not-yet-due
Listed as ongoing, but also has a completion date and reported results 2005-003521-13 Double-blind, randomized, parallel-group, dose ranging, multi-center study to evaluate the efficacy and safety of 2.5, 10, 35 and 50 mg AVE7688 once daily, using 100 mg losartan-potassium once daily a... 2008-04-03 bad-data
Ongoing, reported early 2005-003765-17 Reactogenicity of Acellular Pertussis Vaccine Booster in Adolescents Who Have Received 5 Prior Doses Of BIKEN Acellular Pertussis Vaccine in Combination with Diphtheria and Tetanus Toxoids (Tripedia®)... not-yet-due
Ongoing 2005-003819-71 A double-blind, placebo-controlled study followed by a repeat dosing phase to assess the efficacy and safety of DX-88 recombinant plasma kallikrein inhibitor for the treatment of acute attacks of ... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2005-004006-81 A double-blind, 6 to 12-month, multicenter, multinational, randomized study evaluating the efficacy and safety of SR58611A (350 mg q12) versus placebo in the prevention of relapse / recurrence of depr... 2008-02-01 bad-data
Completed, but no date, and reported results 2005-004034-41 Evaluation of Skeletal Myoblast Transplant for Treating Ischemic Heart Failure Phase 2 Study Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Study bad-data
Other 2005-004068-21 A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study of Ad2/Hypoxia Inducible Factor (HIF)-1alfa/VP16 Administered by Intramuscular Injection to Patients with No ... not-yet-due
Reported results 2005-004133-17 A randomised, controlled, double blind study of the immunogenicity and safety of Pediacel™, a combined diphtheria, tetanus, five component acellular pertussis, inactivated poliomyelitis and Haemophilu... 2007-05-28 due-trials
Completed, but no date, and reported results 2005-004450-27 Follow-up of Thyroid Cancer Patients from Study THYR-008-00 Who Received Thyroid Remnant Ablation Using Either the Hypothyroid or the Thyrogen Method bad-data
Listed as ongoing, but also has a completion date and reported results 2005-004451-35 Study to Evaluate the Dose, Safety and Effectiveness of Modified-Release Recombinant Human Thyroid Stimulating Hormone (MRrhTSH) When Used in Conjunction with Radioiodine for the Treatment of Multin... 2011-07-29 bad-data
Completed, but no date, and reported results 2005-004934-42 Efficacy evaluation of Enterogermina, 2 billion Bacillus clausii spores, on eradication of small intestinal bacterial overgrowth a randomised, parallel-group, open study bad-data
Listed as ongoing, but also has a completion date and reported results 2005-005024-14 A multicenter, randomized, double-blind, parallel-arm, two-stage study of the efficacy and safety of AVE0005 (VEGF Trap) administered intravenously every 2 weeks in patients with platinum-resistant an... 2010-03-29 bad-data
Ongoing, reported early 2005-005026-31 A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm Study of the Effect of Intravenous AVE0005 (VEGF Trap) Administered Every 2 Weeks in Advanced Ovarian Cancer Patients with Rec... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2005-005074-69 Phase II Trial to Evaluate the Efficacy and Safety of Subcutaneously Administered Alemtuzumab (CAMPATH, MabCampath) in Patients with Previously Treated B Cell Chronic Lymphocytic Leukemia 2011-08-19 bad-data
Listed as ongoing, but also has a completion date 2005-005077-29 An International, Phase III, Randomized, Double-Blinded, Placebo-Controlled, Multi-Center Study to Assess the Efficacy of ZD6474 (ZACTIMA ) versus Placebo in Subjects with Unresectable Locally Advance... 2015-11-23 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-005141-19 A 12-week, multicenter, double blind, placebo-controlled, randomized study of the efficacy and safety of 1.0 mg AVE8134 tablets for reducing A1c in the treatment of patients with confirmed type 2 diab... 2007-05-15 bad-data
Reported results 2005-005149-20 Tratamiento neoadyudante con quimioterapia (CapeOxa) y quimioradioterapia (CapeOxa/RT) seguida de cirugía versus quimioradioterapia seguida de cirugía y quimioterapia, en pacientes con cáncer de recto... 2010-11-30 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-005326-30 International, multicenter, randomized, parallel group, double-blind study, in patients with acute symptomatic deep vein thrombosis of the lower limbs, demonstrating the bioequipotency at steady state... 2008-02-01 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-005464-92 A randomized phase II study of docetaxel in combination with oxaliplatin with or without 5-FU or capecitabine in metastatic or locally recurrent gastric cancer previously untreated with chemotherapy f... 2010-04-28 bad-data
Ongoing, reported early 2005-005478-66 Effect of a single oral 120 µg dose of SSR150106XB compared to placebo on the assessment of post dental surgical pain after extraction of an impacted or partially impacted third molar in 90 male and f... not-yet-due
Completed, but no date, and reported results 2005-005481-36 Alfuzosin in Uretheric Stones bad-data
Reported results 2005-005532-27 Comparison of Pertussis Specific Cellular and Humoral Immunity Before and After a Acellular Pertussis Booster-Vaccineation in Combination With a Diphtheria-Tetanus-Polio-Vaccine Between Three Groups o... 2006-10-31 due-trials
Reported results 2005-005597-67 An eight-week, double-blind placebo controlled, multicenter study evaluating the efficacy, safety, tolerability of a fixed dose of SR58611A (350 mg q12) in elderly patients with Major Depressive Disor... 2007-08-21 due-trials
Reported results 2005-005598-30 A NON-INVASIVE EVALUATION OF BONE MICROARCHITECTURE MODIFICATION IN OSTEOPENIC POSTMENOPAUSAL WOMEN BY 3D-PERIPHERAL QUANTITATIVE COMPUTED TOMOGRAPHY : A 24-MONTH, MONOCENTER, DOUBLE-BLIND, RANDOMIZED... 2009-06-22 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-005763-28 Estudio aleatorizado, doble ciego, en el que se comparan los efectos de un régimen de clopidogrel durante 3 meses en combinación con AAS durante el primer mes, frente a AAS en monoterapia, para el tra... 2006-11-08 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-006202-26 A Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel group, Dose Response Study of subcutaneous AVE5026 with an Enoxaparin Calibrator Arm in the Prevention of Venous Thromboembolism in Pati... 2007-05-08 bad-data
Reported results 2006-000122-31 Srovnání fluktuací glykemií při bazální substituci humánním inzulínem NPH a inzulínovým analogem glargine (kontinuální měření glykemií) 2007-11-27 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-000132-27 Estudio de Satavaptan en el Tratamiento de Ascitis Cirrótica: comparación doble ciego, aleatorizada, y con grupos paralelos del tratamiento con satavaptan de 5 a 10 mg diarios frente a placebo añadido... 2008-12-30 bad-data
Reported results 2006-000134-12 Satavaptan en la Prevención de la Recurrencia de Ascitis: comparación doble ciego, aleatorizada, y con grupos paralelos de satavaptan de 5 a 10 mg diarios frente a placebo con diuréticos concomitantes... 2008-10-09 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-000135-10 Satavaptan en la Prevención de la Recurrencia de Ascitis: comparación doble ciego, aleatorizada, y con grupos paralelos de satavaptan de 5 a 10 mg diarios frente a placebo en asuncia de diuréticos en ... 2009-03-03 bad-data
Reported results 2006-000152-41 A multicenter, Randomized, Double Blind, Double Dummy, Parallel Group, Dose Ranging Study of subcutaneous SR123781A with an Enoxaparin calibrator arm in the Prevention of Venous Thromboembolism in Pat... 2007-05-02 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-000313-38 Randomized, multinational, double-blind study, comparing a high loading dose regimen of clopidogrel versus standard dose in patients with unstable angina or myocardial infarction managed with an early... 2010-12-31 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-000324-13 ESTUDIO MULTICÉNTRICO, INTERNACIONAL, ALEATORIZADO, ABIERTO, COMPARATIVO Y DE GRUPOS PARALELOS: OBJETIVOS DEL CONTROL GLUCÉMICO E INCIDENCIA DE HIPOGLUCEMIA SINTOMÁTICA COMPROBADA EN PACIENTES CON DIA... 2008-06-06 bad-data
Ongoing, reported early 2006-000477-29 Safety and immunogenicity of an intramuscular, inactivated, split-virion, pandemic influenza A/H5N1 vaccine in adults and the elderly. not-yet-due
Reported results 2006-000506-22 A randomized, double-blind, triple-dummy, dose-ranging study, including an active control of unfractionated heparin and eptifibatide, to evaluate the clinical efficacy and safety of otamixaban, in pat... 2009-03-01 due-trials
Reported results 2006-000604-16 A Multicenter, Open-Label, Single-Arm Study of Intravenous AVE0005 VEGF Trap Administered Every 2 Weeks in Advanced Ovarian Cancer Patients with Recurrent Symptomatic Malignant Ascites 2008-11-06 due-trials
Ongoing, reported early 2006-000671-15 Immunogenicity and Safety of the Inactivated, Split-Virion Influenza Vaccine, Northern Hemisphere 2006-2007 Formulation (Intramuscular Route) not-yet-due
Completed, but no date 2006-000715-19 A Long-Term Safety and Immunogenicity Follow-up of Healthy Adults Vaccinated with One Dose of Smallpox Vaccine (LISTER Strain). bad-data
Reported results 2006-000763-29 Pharmacokinetics, pharmacodynamics and safety of intra-articular multiple doses of 500 mcg icatibant in an uncontrolled 13-week multi-center study in patients with symptomatic knee osteoarthritis 2006-10-31 due-trials
Reported results 2006-000898-30 Safety and Immunogenicity of Booster Vaccination with PEDIACEL®, a Combined Diphtheria, Tetanus, Five Component Acellular Pertussis, Inactivated Poliomyelitis and Haemophilus Influenzae Type b Conjuga... 2007-09-17 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-000946-38 International randomized double blind clinical study evaluating the efficacy and safety of clopidogrel 0.2mg/kg once daily versus placebo in neonates and infants with cyanotic congenital heart disea... 2010-02-01 bad-data
No trial status on register 2006-001095-21 Immunogenicity and Safety of PEDIACEL®, a Combined Diphtheria, Tetanus, Five Component Acellular Pertussis, Inactivated Poliomyelitis and Haemophilus influenzae Type b Conjugate Vaccine (Adsorbed), Co... bad-data
Listed as ongoing, but also has a completion date and reported results 2006-001099-20 An international, seven-week, double blind, placebo-controlled, two parallel group study to assess the efficacy of dianicline 40 mg bid as an aid to smoking cessation in cigarette smokers 2007-10-23 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-001152-12 An international, multi-center, randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of two year treatment with teriflunomide 7 mg once daily and 14 m... 2016-02-05 bad-data
Completed, but no date 2006-001248-30 A multicenter, randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy of ciclesonide metered-dose inhaler at a daily dose of 160 μg administered either in a once-dai... bad-data
Reported results 2006-001341-34 Open label, uncontrolled study of XRP9881 in combination with trastuzumab (Herceptin®) in patients with HER2 positive metastatic breast cancer (MBC) 2011-01-24 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-001711-30 A Pan-European randomized, parallel group, two-arm placebo-controlled, double-blind multicenter study of Rimonabant 20mg once daily in the treatment of abdominally obese patients with impaired fasting... 2009-04-02 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-001715-30 A European randomized, parallel group, two-arm placebo-controlled, double-blind multicenter study of Rimonabant 20mg once daily in the treatment of abdominally obese patients with dyslipidemia with or... 2009-01-30 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-001716-71 A RANDOMIZED, DOUBLE BLIND, TWO ARM, PARALLEL, PLACEBO CONTROLLED STUDY OF RIMONABANT 20MG EFFECT ON HIGH DENSITY LIPOPROTEIN KINETICS IN PATIENTS WITH ABDOMINAL OBESITY AND ADDITIONAL CARDIOMETABOLIC... 2008-12-18 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-001786-42 An international, multicenter, randomized, double-blind, double-dummy, parallel group, study of 3-month or 6-month treatment with SSR126517E 3.0 mg s.c. once weekly versus oral INR-adjusted warfarin... 2010-11-10 bad-data
Reported results 2006-001843-74 A randomized, double-blind, parallel-group, placebo-controlled, dose-response, multicentre, multinational study evaluating the efficacy and safety of AVE2268 administered either twice daily breakfast... 2008-01-07 due-trials
Ongoing 2006-001910-33 A Multicenter, Multinational Study of the Effects of Fabrazyme® (agalsidase beta) Treatment on Lactation and Infants not-yet-due
Listed as ongoing, but also has a completion date and reported results 2006-002253-71 A double-blind, multi-center, randomized withdrawal study evaluating the efficacy and safety of Amibegron 350 mg twice a day versus placebo in the prevention of relapse of anxiety up to 1 year in pa... 2007-12-09 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-002317-12 A double-blind placebo-controlled study of the activity of AVE1625 at doses of 10 mg and 40mg for 12 weeks in patients with mild to moderate Alzheimer s Disease 2007-07-12 bad-data
Reported results 2006-002366-18 Immunogenicity of the Investigational Inactivated, Split-Virion Influenza Vaccine Administered by the Intradermal Route in Comparison with the Intramuscular Reference Vaccine Vaxigrip in the Elderl... 2009-06-16 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-002369-37 Estudio sobre la consistencia lote a lote de la vacuna en investigación contra la gripe de virión fraccionado inactivado administrada por vía intradérmica en adultos 2007-06-06 bad-data
Completed, but no date, and reported results 2006-002482-39 Evaluation of the effects of Enterogermina, 2 billion Bacillus clausii spores, on the intestinal flora of children antibiotic treated for bacterial upper respiratory tract infections open, pilot stud... bad-data
Completed, but no date, and reported results 2006-002847-96 A 13-week Multinational, Randomized, Double-Blind, Placebo-Controlled, Dose-Response Trial Assessing the Safety, Tolerability and Efficacy of AVE0010 in Metformin-Treated Subjects with Type 2 Diabetes... bad-data
Ongoing, reported early 2006-002951-33 A 12-month multicentre, randomised, double-blind, placebo-controlled study with two parallel groups to assess the effects of rimonabant 20 mg in patients with abdominal obesity and microalbuminuria, w... not-yet-due
Ongoing, reported early 2006-003085-34 A Dose-escalating, Multicenter, Single arm, Open-label Study of XRP6258 in combination with capecitabine (Xeloda®), in patients with metastatic breast cancer with disease progressing after anthracycli... not-yet-due
Ongoing, reported early 2006-003086-14 A Randomized, Open Label Multi-Center Study of Single Agent Larotaxel XRP9881 at 90 mg/m2 every 3 weeks Compared to Continuous Administration of 5-FU For The Treatment of Patients With Advanced Panc... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2006-003087-59 A Randomized, Open Label Multi-Center Study of XRP6258 At 25 mg/m2 in Combination With Prednisone Every 3 Weeks Compared To Mitoxantrone in Combination With Prednisone For The Treatment of Hormone Ref... 2009-09-25 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-003134-14 A randomized, multinational, double-blind, placebo-controlled, parallel-group design pilot study to estimate the tolerability, safety, pharmacokinetics, and pharmacodynamic effects of teriflunomide fo... 2010-04-07 bad-data
Reported results 2006-003138-13 A randomized, double-blind, placebo-controlled, multinational study evaluating the safety and pharmacokinetics of 5 and 10 µg AVE0010 single doses and the efficacy, safety and pharmacokinetics of AVE0... 2007-09-17 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-003361-14 Long-term extension of the multinational, double-blind, placebo controlled study EFC6049 HMR1726D/3001 to document the safety of two doses of teriflunomide 7 and 14 mg in patients with multiple sc... 2015-12-23 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-003644-31 An Open-Label Extension Study of Patients with Late-Onset Pompe Disease Who Were Previously Enrolled in Protocol AGLU02704 2008-11-13 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-003793-94 An Eight-Week, Multinational, Multicenter, Randomized, Double-blind, Placebo-controlled Study, with Escitalopram as an Active Control, to Evaluate the Efficacy, Safety and Tolerability of a Saredutant... 2008-07-21 bad-data
Reported results 2006-003805-19 An eight-week, multinational, multicenter, randomized, double-blind, placebo-controlled study, with escitalopram as an active control, to evaluate the efficacy, safety and tolerability of a saredutant... 2008-04-03 due-trials
Completed, but no date, and reported results 2006-003886-15 Steady state telithromycin pharmacokinetics and pharmacodynamic in adult patients with mild-moderate acute exacerbation of chronic obstructive pulmonary disease treated with a standard oral dose 8... bad-data
Reported results 2006-004146-16 A multi-national, multi-center, double blind, placebo-controlled, parallel group, fixed dose efficacy and safety study of SR58611A 350 mg twice daily vs. placebo in adults with Major Depressive Disord... 2008-02-22 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-004147-33 An Eight-Week, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Fixed Dose of SR58611A 350 mg Twice a Day in Elderly Patients with Generalized Anx... 2007-09-14 bad-data
Reported results 2006-004247-29 A Multicenter, Randomized, Comparative, Patient-blinded Study to Evaluate the Safety and Efficacy of G-CSF Alone Versus AMD3100 (240 µg/kg) Added to a G-CSF Mobilization Regimen in Adult Patients with... 2009-06-23 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-004275-35 A randomized, double-blind, placebo-controlled, parallel group trial of HMR1766 assessing the efficacy and safety of 3 doses of HMR1766 (25, 100, 200 mg OD) versus placebo with cilostazol, 100 mg BID ... 2008-09-15 bad-data
Completed, but no date, and reported results 2006-004740-22 A multicenter, multi-national, randomized, double-blind, placebo-controlled, study to assess the efficacy and safety of ciclesonide metered-dose inhaler at 80 μg BID or 40 μg BID for 12 weeks in patie... bad-data
Listed as ongoing, but also has a completion date and reported results 2006-004756-20 A Multicenter, Randomized, Double-Blind Study Comparing the Efficacy and Safety of Aflibercept Versus Placebo Administered Every 3 Weeks in Patients Treated with Docetaxel / Prednisone for Metastatic ... 2012-04-17 bad-data
Reported results 2006-004817-16 A Prospective, Randomized, Open-Label, Parallel-Group, Multicenter Study to Demonstrate the Superiority of Matrix-induced Autologous Chondrocyte Implantation (MACI® implant) versus Arthroscopic Micro... 2013-03-20 due-trials
Completed, but no date, and reported results 2006-004840-21 Bone Histomorphometry, Microarchitecture and Matrix Structure and Properties in Patients Receiving Long-term Risedronate Treatment bad-data
Listed as ongoing, but also has a completion date and reported results 2006-004893-29 A randomized, multinational, double-blind, placebo-controlled, parallel-group design pilot study to estimate the tolerability, safety, pharmacokinetics, and pharmacodynamic effects of teriflunomide fo... 2010-06-09 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-004942-18 Efficacy and safety of 2 mg/day of M100907 on Sleep Maintenance Insomnia with a sub-study of the effect of M100907 on stable Type II Diabetes Mellitus a One Year, multi-center, randomized, double-bli... 2009-03-11 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-005303-34 Efficacy and safety of 2 mg/day M100907 on Sleep Maintenance Insomnia: a 6-week, multicenter, randomized, double-blind, placebo-controlled Polysomnographic study 2008-01-16 bad-data
Reported results 2006-005320-16 Long-term Observational Follow-up Study of a Multicenter, Randomized, Double-blind, Placebo-controlled, Comparative Trial of AMD3100 (240 µg/kg) plus G-CSF (10 µg/kg) Versus G-CSF (10 µg/kg) plus Plac... 2011-07-29 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-005334-21 A randomized, double-blind, placebo-controlled, parallel group, fixed-dose, 8-week treatment, multi-center trial evaluating the dose effect relationship for efficacy and the safety of 3 oral doses of ... 2008-04-04 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-005385-39 A Randomized, Double-Blind, Parallel-Group, Multicenter, Multinational Study to Assess Glycemic Control with Rimonabant in Comparison with Glimepiride over 1 Year in Overweight/Obese Type 2 Diabetic P... 2009-03-04 bad-data
Reported results 2006-005422-23 An open-label, multicenter study evaluating the long-term safety of satavaptan (SR121463B) and maintenance of normonatremia in patients with dilutional hyponatremia who have previously been treated in... 2008-10-06 due-trials
Ongoing, reported early 2006-005469-20 A randomized, double-blind, parallel-group, placebo-controlled, ezetimibe-calibrated, multicenter study evaluating the safety and efficacy of four doses and two dose-regimens of AVE5530 over 4 weeks i... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2006-005753-29 A single-blind, placebo-controlled, multicentre study evaluating continued long-term treatment with satavaptan (SR121463B) in patients with ascites due to liver cirrhosis who have previously been trea... 2008-12-12 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-005804-15 Randomized double blind trial to evaluate the efficacy and safety of dronedarone (400 mg BID) versus amiodarone (600 mg daily for 28 days then 200 mg daily thereafter) for at least 6 months for the ma... 2008-10-03 bad-data
Completed, but no date, and reported results 2006-005946-35 Efficacy and safety of 3 intra-articular injections of 500 µg icatibant in a randomized, double-blind, parallel-group, placebo-controlled 13-week multi-centre study in patients with symptomatic knee o... bad-data
Other 2006-005978-51 Uncontrolled, multicenter, dose finding, safety and pharmacokinetic study of AVE1642, an anti-Insulin-like Growth Factor-1 Receptor (IGF-1R/ CD221) monoclonal antibody, administered as single agent an... not-yet-due
Ongoing, reported early 2006-006144-55 A multicenter, open-label, single-arm, two-stage study of the efficacy and safety of AVE0005 (VEGF Trap) administered intravenously every 2 weeks in patients with platinum- and erlotinib-resistant, lo... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2006-006152-34 A Multicenter, Open-Label, Single Arm Study of Weekly Alvocidib in Patients with Previously Treated B-Cell Chronic Lymphocytic Leukemia (CLL) or Prolymphocytic Leukemia (PLL) Arising from CLL 2012-01-16 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-006277-24 A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED PARALLEL GROUP STUDY OF THE EFFICACY AND SAFETY OF 4 ADMINISTRATIONS OF XRP0038/NV1FGF 4mg AT 2–WEEK INTERVALS ON AMPUTATION OR ANY DEATH IN CRITICAL LIMB ... 2012-08-08 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-006473-24 A randomized, open-label, multi-center study of larotaxel at 90mg/m² or docetaxel every 3 weeks, alone or in combination with trastuzumab according to Her2neu status, administered after a combination ... 2010-03-31 bad-data
Ongoing, reported early 2006-006474-21 A dose-escalating, multicenter, single arm, open-label study of XRP9881 in combination with capecitabine (Xeloda®), in metastatic breast cancer patients with disease progressing after anthracycline an... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2006-006521-30 Long term safety and tolerability of satavaptan in patients with cirrhosis of the liver that have been previously randomized and completed treatment in any of the phase III studies: EFC4492; EFC4493 o... 2009-01-10 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-006677-25 Efficacy and safety of 2mg/day of M100907 on Sleep Maintenance Insomnia with a sub-study of the effect of M100907 on stable Type II Diabetes Mellitus: a 12-week, multi-center, randomized, double-blind... 2008-10-30 bad-data
Reported results 2007-000323-17 A Randomized, Open Label, Multicenter, Phase III, 2-Arm Study of Androgen Deprivation with Leuprolide, +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Subjects with a Rising PSA Following De... 2012-10-05 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-000582-37 A Phase 4 Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Centre Study of Colesevelam as Add-on Therapy in Patients with Familial Hypercholesterolaemia 2009-10-22 bad-data
Reported results 2007-000752-14 Immunogenicity and Safety of the Inactivated, Split-Virion Influenza Vaccine, Northern Hemisphere 2007-2008 Formulation (Intramuscular Route) 2007-07-03 due-trials
Reported results 2007-000760-24 Activity and safety of oral administration of SSR150106XB for the reduction of inflammation in patients with active rheumatoid arthritis (RA): A 4-week, multi-center, randomized, double-blind, placebo... 2011-11-15 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-000819-29 A Multinational, Randomized, Double-Blind Study Comparing Aflibercept Versus Placebo in Patients Treated with Second-Line Docetaxel after Failure of One Platinum Based Therapy for Locally Advanced or ... 2011-10-04 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-000820-42 A Multinational, Randomized, Double-blind Study, Comparing the Efficacy of Aflibercept Once Every 2 Weeks versus Placebo in Patients with Metastatic Colorectal Cancer (MCRC) Treated with Irinotecan /... 2012-06-29 bad-data
Reported results 2007-000886-40 Assessment of the early efficacy response rate of leflunomide according to the initial dosing regimen in the treatment of naive - DMARD early RA-patients. 2009-10-16 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-000945-36 A multi-center, randomized, double blind, placebo controlled Phase III study to assess the efficacy of xaliproden in patients with oxaliplatin-induced peripheral sensory neuropathy (PSN) following adj... 2009-11-27 bad-data
Reported results 2007-000983-26 12-week, multicenter, open-label, non-comparative study to investigate pharmacodynamic and safety of alfuzosin 0.2 mg/kg/day in the treatment of children and adolescents 2 - 16 years of age with hydro... 2009-10-09 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-001043-22 A Multicenter, Open-Label Study of Hectorol (doxercalciferol capsules) for the Treatment of Secondary Hyperparathyroidism in Stage 3 or Stage 4 Chronic Kidney Disease (CKD) Patients 2007-12-17 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-001161-14 A Phase 3 Randomized, Rater-Blinded Study Comparing Two Annual Cycles of Intravenous Alemtuzumab to Three-Times Weekly Subcutaneous Interferon Beta-1a (Rebif®) in treatment Naïve Patients with Relapsi... 2011-04-27 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-001162-32 A Phase 3 Randomized, Rater- and Dose-Blinded Study Comparing Two Annual Cycles of Intravenous Low- and High-Dose Alemtuzumab to Three-Times Weekly Subcutaneous Interferon Beta-1a (Rebif®) in Patients... 2011-09-15 bad-data
No trial status on register 2007-001163-30 A trial of antigen-specific immune tolerance induction in mucopolysaccharidosis I (MPS I) patients initiating enzyme replacement therapy with Aldurazyme® (laronidase) bad-data
Listed as ongoing, but also has a completion date and reported results 2007-001211-33 International randomized study to evaluate the addition of docetaxel to the combination of cisplatin-5-fluorouracil (TCF) vs. cisplatin-5-fluorouracil (CF) in the induction treatment of nasopharyngeal... 2012-02-23 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-001639-80 A multicenter, double-blind, parallel-group, placebo-controlled study of the effect on cognitive performance and safety/tolerability of SSR180711C, at the doses of 2, 8 and 20 mg/d for 4 weeks, using ... 2008-07-24 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-001852-38 A Multicenter, Open-Label, Randomized Study comparing Efficacy and Safety of S-1 as a Single Agent at 30 mg/m2 BID versus 5-FU Bolus for the Treatment of Patients with Metastatic Pancreatic Cancer Pr... 2010-06-08 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-001943-23 Randomized Study of LAROTAXEL + Cisplatin (LC) vs. Gemcitabine + Cisplatin (GC) in the First Line Treatment of Locally Advanced /Metastatic Urothelial Tract or Bladder Cancer 2011-02-16 bad-data
Completed, but no date, and reported results 2007-002077-31 Effects of Rimonabant on urinary albumin excretion rate on the components of the metabolic syndrome in patients with type 2 diabetes mellitus and microalbuminuria on background ramipril treatment. A p... bad-data
Ongoing, reported early 2007-002104-18 Evaluation of the Cellular, Humoral and Mucosal Immune Response in Adults and Elderly Subjects Vaccinated either with an Inactivated Influenza Vaccine Administered via the Intradermal Route or an Inac... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2007-002172-34 A double-blind, randomized, placebo-controlled, study evaluating the safety and activity of four escalating single doses of AVE0657 in congestive heart failure patients presenting as Cheyne-Stokes Bre... 2009-03-30 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-002174-58 A double-blind, randomized, placebo-controlled, study of the safety and activity of four escalating single doses of AVE0657 in patients suffering from Obstructive Sleep Apnea Hypopnea Syndrome 2009-01-19 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-002492-14 A randomized, double-blind, parallel-group, multicenter, multinational study to assess the long-term effect, over 1 year, of rimonabant 10 mg in comparison with rimonabant 20 mg after an initial treat... 2009-02-27 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-002532-28 A Phase II Study of Efficacy of Rabbit Anti-thymocyte Globulin (rATG) in patients with Low and Itermediate-1 Risk Mylodysplastic Syndrome 2009-05-06 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-003012-61 A double-blind, randomized, placebo-controlled, parallel group study of rimonabant 20 mg daily for the treatment of non-diabetic patients with nonalcoholic steatohepatitis (NASH) 2009-02-27 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-003013-14 A double-blind, randomized, placebo-controlled, parallel group study of rimonabant 20 mg daily for the treatment of Type 2 diabetic patients with nonalcoholic steatohepatitis (NASH) 2009-02-23 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-003159-36 An eight-week, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of saredutant 100 mg once daily in combination with escitalopram 10 mg once daily in patients w... 2009-01-14 bad-data
Completed, but no date, and reported results 2007-003393-25 COBIN2 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-003476-19 A Multinational, Randomized, Double-Blind Study, Comparing the Efficacy of Aflibercept Once Every 2 Weeks versus Placebo in Patients Treated with Gemcitabine for Metastatic Pancreatic Cancer 2010-11-26 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-003579-38 Efecto de la insulina glulisina en comparación con la insulina aspart y la insulina lispro cuando se administran mediante Infusión Subcutánea Continua de Insulina (ISCI) sobre parámetros específicos d... 2009-06-15 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-003592-39 A multinational, randomized, double-blind placebo controlled study of AVE8062 (25 mg/m²) administered every 3 weeks in patients with advanced-stage soft tissue sarcoma, treated with cisplatin (75 mg/m... 2013-04-17 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-003822-28 Comparison of the safety and efficacy of eplivanserin and lormetazepam in the treatment of insomnia characterized by sleep maintenance difficulties. A 4 week, randomized, double-blind, comparative, pa... 2009-03-06 bad-data
Reported results 2007-003863-31 An eight-week, double-blind study to evaluate the efficacy, safety, and tolerability of two fixed doses of saredutant (100 mg and 30 mg) once daily in combination with paroxetine 20 mg once daily comp... 2009-02-27 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-003885-16 A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Sevelamer Carbonate Tablets Dosed Three Times a Day in Hyperphosphataemic Chronic Kidney Disease Patients... 2009-08-20 bad-data
Reported results 2007-003997-24 Long-term extension of the multinational, double-blind, placebo controlled study PDY6045 and PDY6046 to document the safety of teriflunomide when added to treatment with interferon-beta or glatiramer ... 2010-04-30 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-004126-24 A placebo controlled randomized, 12-week, dose-ranging, double-blind study versus placebo using tolterodine as a study calibrator, to evaluate efficacy and safety of SSR240600C in women with overactiv... 2009-02-07 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-004452-36 A multi-center double-blind parallel-group placebo-controlled study of the efficacy and safety of teriflunomide in patients with relapsing multiple sclerosis 2015-06-18 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-004817-33 A multicenter, randomized, double-blind, assessor-blind, non-inferiority study comparing the efficacy and safety of once-weekly subcutaneous biotinylated idraparinux (SSR126517E) with oral adjusted-d... 2010-11-01 bad-data
Reported results 2007-004833-40 A randomized, double blind, placebo controlled study evaluating the glycemic effect of rimonabant added to metformin in patients with type 2 diabetes insufficiently controlled with metformin monothera... 2009-02-18 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-005668-28 A Randomized, Multicenter, Multinational, Phase 3B, Open-Label, Parallel-Group Study of Fabrazyme (agalsidase beta) in Treatment-Naive Male Pediatric Patients with Fabry Disease Without Severe Symptom... 2015-06-22 bad-data
Reported results 2007-005772-13 Comparative efficacy of amisulpride vs. risperidone on cognitive functions in patients with chronic schizophrenia. 2010-01-15 due-trials
Reported results 2007-005880-80 A randomized, double-blind, placebo-controlled, parallel-group, multicenter 24-week study followed by an extension assessing the efficacy and safety of AVE0010 on top of metformin in patients with typ... 2011-03-09 due-trials
Reported results 2007-005881-11 A randomized, double-blind, placebo-controlled, 2-arm parallel-group, multicenter 24-week study followed by an extension assessing the efficacy and safety of AVE0010 on top of a sulfonylurea in patien... 2011-01-14 due-trials
Reported results 2007-005883-28 A randomized, open-label, active-controlled, 2-arm parallel-group, multicenter 24-week study followed by an extension assessing the efficacy and safety of AVE0010 versus exenatide on top of metformin ... 2010-11-18 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-005884-92 A randomized, double-blind, placebo-controlled, 2-arm parallel-group, multicenter study with a 24-week main treatment period and an extension assessing the efficacy and safety of AVE0010 on top of pio... 2011-06-29 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-005886-36 A randomized, double-blind, placebo-controlled, 2-arm parallel-group, multicenter study with a 24-week main treatment period and an extension assessing the efficacy and safety of AVE0010 in patients w... 2011-02-08 bad-data
Completed, but no date, and reported results 2007-005887-29 A randomized, double-blind, placebo-controlled, parallel-group, multicenter 12-week study assessing the efficacy and safety of AVE0010 in patients with type 2 diabetes not treated with antidiabetic ag... bad-data
Listed as ongoing, but also has a completion date and reported results 2007-006640-22 Superioridad de insulina glargina Lantus frente a NPH: “Tratar hasta alcanzar la Normoglucemia”. Comparación del efecto de insulina glargina vs insulina NPH en pacientes con diabetes mellitus de tipo... 2012-07-17 bad-data
Ongoing 2007-007003-33 A Multicenter, Multinational, Open-Label Study of the Effects of Aldurazyme(laronidase) Treatment on Lactation in Women with Mucopolysaccharidosis I (MPS I) and Their Breastfed Infants not-yet-due
Listed as ongoing, but also has a completion date and reported results 2007-007941-10 A Double-Blind, Randomized, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of two doses of Satavaptan (SR121463B) Versus Placebo in Patients with Dilutional Hyponatremia due t... 2008-11-10 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-007942-36 A Multinational, Multicenter, Randomized, Double Blind Study comparing the Efficacy and Safety of AVE5026 with enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdo... 2010-08-12 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-007943-29 A multinational, randomized, double blind, placebo-controlled study to evaluate the efficacy and safety of AVE5026 in the prevention of venous thromboembolism (VTE) in cancer patients at high risk for... 2010-11-18 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-007944-80 A Multinational, Multicenter, Randomized, Double-blind Study Comparing the Efficacy and Safety of AVE5026 with enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Elective T... 2009-06-30 bad-data
Reported results 2007-007945-11 A Multinational, Multicenter, Randomized, Double-Blind study Comparing the Efficacy and Safety of AVE5026 with enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Hip Fractu... 2009-10-28 due-trials
Reported results 2007-007946-37 A Multinational, Multicenter, Randomized, Double-blind Study Comparing the Efficacy and Safety of AVE5026 with enoxaparin for the prevention of Venous Thromboembolism in Patients Undergoing Elective K... 2009-05-11 due-trials
Reported results 2007-007947-28 A Multinational, Multicenter, Randomized, Double-Blind study Comparing the Efficacy and Safety of AVE5026 with placebo for the Extended Prevention of Venous Thromboembolism in Patients Having Undergon... 2010-01-22 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-000228-13 A Multinational, Multicenter, Randomized, Double-Blind Study Comparing the Efficacy and Safety of AVE5026 with enoxaparin for the Primary Prevention of Venous Thromboembolism in Acutely Ill Medical Pa... 2009-03-16 bad-data
Reported results 2008-000516-32 Estudio de superioridad de insulina glargina frente a sitagliptina en pacientes con diabetes tipo 2, sin experiencia previa de insulinoterapia, que reciben tratamiento con metformina y no están sufici... 2011-07-21 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-000521-19 Combination therapy of insulin glargine and sitagliptin in patients with type 2 diabetes not adequately controlled by a previous treatment with metformin and either insulin glargine or sitagliptin (Ex... 2011-09-09 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-000689-21 Plerixafor and G-CSF for the Mobilisation of Peripheral Blood Stem Cells for Autologous Stem Cell Transplantation in Patients with Non-Hodgkin’s Lymphoma (NHL), Hodgkin’s Disease (HD) or Multiple My... 2010-11-18 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-000810-54 Multicenter, randomized, open label study evaluating an anti Insulin-like Growth Factor-1 Receptor (IGF-1R/CD221) monoclonal antibody, AVE1642, administered every 4 weeks in combination with fulvestra... 2010-11-10 bad-data
Reported results 2008-000943-33 Immunogenicity and Safety of the Inactivated, Split-Virion Influenza Vaccine, Northern Hemisphere 2008-2009 Formulation (Intramuscular Route) 2008-07-23 due-trials
Reported results 2008-001002-16 A randomized, double-blind, placebo-controlled, parallel-group, multicenter, 24-week study followed by an extension assessing the efficacy and safety of AVE0010 in two titration regimens on top of met... 2011-09-16 due-trials
Ongoing, reported early 2008-001043-19 A Phase III Randomized, Double-Blind, Controlled Study Comparing Clofarabine and Cytarabine versus Cytarabine Alone in Adult Patients 55 Years and Older with Acute Myelogenous Leukemia (AML) who have ... not-yet-due
Ongoing, reported early 2008-001219-39 Immunogenicity and Safety of the Investigational Inactivated, Split-Virion Influenza Vaccine 15 µg Administered by the Intradermal Route in Comparison with the Intramuscular Reference Vaccine Vaxigrip... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2008-001492-30 Comparación de la seguridad y eficacia de volinanserina y lormetazepam en el tratamiento del insomnio caracterizado por la dificultad para mantener el sueño. Estudio comparativo, aleatorizado, doble c... 2009-01-30 bad-data
Reported results 2008-001518-26 Efficacy and safety of oral ataciguat (HMR1766) 200 mg administered once daily for 28 days on pain reduction in patients with Neuropathic Pain. A randomized, double-blind, placebo-controlled, cross-ov... 2009-09-10 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-001550-41 A multicenter, double-blind, randomized, 12-month, placebo-controlled study to evaluate the lipid-lowering effect, safety and tolerability of AVE5530 25 mg/day and 50mg/day when added to ongoing stabl... 2009-06-11 bad-data
Reported results 2008-001718-26 An eight-week, multicenter, randomized, double-blind, placebo-controlled dose-finding study, with escitalopram (10mg daily) as active control, to evaluate the efficacy, safety and tolerability of thre... 2010-02-16 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-001999-67 A 14-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Nerispirdine 50 mg, 100 mg, and 200 mg in Patients with Multiple Scl... 2010-03-02 bad-data
Completed, but no date 2008-002500-26 A multicenter, double blind, placebo controlled randomized study of the efficacy and safety of two rimonabant/metformin combinations for reducing A1C in the treatment of patients with type 2 diabetes ... bad-data
Listed as ongoing, but also has a completion date and reported results 2008-002849-23 A multicenter, double-blind, randomized, placebo-controlled study to evaluate the efficacy, safety and tolerability of AVE5530 when added to ongoing stable statin therapy at high doses in patients wit... 2009-06-11 bad-data
Ongoing, reported early 2008-003284-39 Etude nationale, multicentrique, non comparative, évaluant l’efficacité de l’association lévofloxacine (500 mg) et rifampicine (600 ou 900 mg selon le poids) administrée une fois par jour par voie ora... not-yet-due
Ongoing, reported early 2008-003375-41 Etude de non-infériorité Bi-Profénid® 200 mg versus Bi-Profénid® 300 mg chez des patients présentant des douleurs liées à des affections aiguës bénignes fermées post-traumatiques de l'appareil locomot... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2008-003791-22 Efficacy and safety of eplivanserin 5mg/day in insomnia characterized by sleep maintenance difficulties: a 6-week, randomized, double-blind, placebo-controlled, polysomnography study 2009-06-05 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-004178-41 Estudio aleatorizado, multinacional de Aflibercept y FOLFOX6 modificado como tratamiento de primera línea para pacientes con cáncer colorrectal metastático 2012-01-11 bad-data
Reported results 2008-004907-69 A Phase II randomized, placebo-controlled, double-blind, dose ranging study of a Clostridium difficile toxoid vaccine (ACAM-CDIFF) in subjects with Clostridium difficile-associated infection(CDI) 2011-07-11 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-004999-53 Estudio de seguridad a largo plazo en los pacientes incluidos en el estudio CLARINET con cardiopatía congénita cianosante paliada con derivación sistémica a la arteria pulmonar en los cuales persista ... 2010-07-21 bad-data
Reported results 2008-005127-29 MULTICENTER PHASE III RANDOMIZED TRIAL COMPARING DOXORUBICIN AND CYCLOPHOSPHAMIDE FOLLOWED BY DOCETAXEL (AC->T) WITH DOXORUBICIN AND CYCLOPHOSPHAMIDE FOLLOWED BY DOCETAXEL AND TRASTUZUMAB (HERCEPTIN®)... 2014-12-30 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-005222-37 A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study Confirming the Efficacy and Safety of Genz-112638 in Patients with Gaucher Disease Type 1 2016-01-21 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-005223-28 A Phase 3, Randomized, Multi-Center, Multi-National, Open-Label, Active Comparator Study to Evaluate the Efficacy and Safety of Genz-112638 in Patients with Gaucher Disease Type 1 who have been Stabi... 2015-06-02 bad-data
Reported results 2008-005791-27 Safety and Immunogenicity of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in European Children 2010-01-18 due-trials
Reported results 2008-006020-53 A Prospective Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Mipomersen in Patients With Severe Hypercholesterolemia on a Maximally Tolerated Lipid-Lowering Re... 2010-10-14 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-006226-34 A multi-center, randomized, parallel-group, rater-blinded study comparing the effectiveness and safety of teriflunomide and interferon beta-1a in patients with relapsing multiple sclerosis 2015-05-13 bad-data
Reported results 2008-006796-80 The QUTIE Study: A Randomized, Double-Blind, Placebo-controlled Study Comparing Aflibercept Versus Placebo on the QTc interval in Cancer Patients treated with Docetaxel 2010-11-08 due-trials
Ongoing, reported early 2008-007026-19 COMPARISON OF A BASAL PLUS ONE INSULIN REGIMEN (INSULIN GLARGINE/INSULIN GLULISINE) WITH A BIPHASIC INSULIN REGIMEN (INSULIN ASPART/INSULIN ASPART PROTAMINE 30/70) IN TYPE 2 DIABETES PATIENTS FOLLOWIN... not-yet-due
Reported results 2008-007334-22 A randomized, double-blind, double-dummy, 2-arm parallel-group, multicenter 24-week study comparing the efficacy and safety of AVE0010 to sitagliptin as add-on to metformin in obese type 2 diabetic pa... 2011-03-21 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-007335-40 A randomized, placebo-controlled, 2-arm parallel-group, multicenter study with a 24-week double-blind treatment period assessing the efficacy and safety of lixisenatide in patients with Type 2 diabet... 2011-08-01 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-008265-36 “A randomised, double-blind, placebo-controlled, parallel-group study of the efficacy and safety of two doses of ketoprofen (as lysinate) lozenges (6.25 mg and 12.5 mg) in patients with sore throat” 2010-04-27 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-008412-47 Double blind placebo controlled dose ranging study of the efficacy and safety of celivarone at 50, 100 or 300 mg OD with Amiodarone as calibrator for the prevention of ICD interventions or death 2011-05-12 bad-data
Ongoing, reported early 2009-009877-85 Immunogenicity of the Purified Vero Rabies Vaccine – Serum Free in Comparison with the Reference Purified Vero Rabies Vaccine in Pre-exposure Use in Healthy Adults not-yet-due
Ongoing, reported early 2009-009936-56 Randomized, double-blind, placebo and active controlled study of the activity of SAR407899A single-dose on the ability to increase duration of penile rigidity, under experimental condition, in patient... not-yet-due
Ongoing, reported early 2009-009977-85 Immunogenicity and Safety of the Influenza Vaccine (Split Virion, Inactivated), Northern Hemisphere 2009-2010 Formulation (Intradermal Route) not-yet-due
Listed as ongoing, but also has a completion date and reported results 2009-010339-42 An eight-week, multinational, multicenter, double-blind, active- and placebo-controlled clinical trial evaluating the efficacy and tolerability of three fixed doses of SSR125543 (20 mg daily, 50 mg da... 2011-03-14 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-010788-18 An Extension Protocol For Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab 2016-02-16 bad-data
Reported results 2009-010913-59 Health Assessment, Patient treatment satisfaction and Quality-of-Life in insulin-naive type 2 diabetes Patients uncontrolled on OHA treatment initiating basal insulin therapy with either insulin glarg... 2012-10-16 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-011231-12 A 24-week, randomized, open-label, parallel group multinational comparison of Lantus® (insulin glargine) given in the morning as once-a-day basal insulin versus Neutral Protamine Hagedorn (NPH) insuli... 2011-03-30 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-012852-26 A randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate cardiovascular outcomes during treatment with lixisenatide in type 2 diabetic patients after an Acute Coro... 2015-02-11 bad-data
Ongoing, reported early 2009-013344-37 Immunogenicity and Safety of Multiple Formulations of an Intramuscular Inactivated, Split Virion Swine-Origin A/H1N1 Influenza Vaccine With and Without Adjuvant in Healthy European Adult and Elderly s... not-yet-due
Completed, but no date, and reported results 2009-013346-83 Immunogenicity and Safety of Multiple Formulations of an Intramuscular Inactivated, Split Virion Swine-origin A/H1N1 Influenza Vaccine With and Without Adjuvant in Healthy European Subjects Aged 3 to ... bad-data
Reported results 2009-013858-32 Immunogenicity and Safety of Multiple Formulations of an Intramuscular Inactivated, Split Virion Swine-origin A/H1N1 Influenza Vaccine With and Without Adjuvant in Healthy European Subjects Aged 6 to ... 2011-01-05 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-015066-61 Efficacy and safety of SAR407899A in patients with painful diabetic neuropathy. A 28-day, randomized, double-blind, placebo-controlled, parallel-group study. 2010-01-15 bad-data
Completed, but no date, and reported results 2009-015742-34 Better Accepance of a Singe injection Apidra (insulin glulisine) Added to once daily Lantus (insulin glargine) versus twice daily Premixed insulin in a real Life Use Setting. bad-data
Reported results 2009-015811-42 A Phase 3, Randomized, Multi-Center, Multi-National, Double-Blind Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Once Daily versus Twice Daily Dosing of Genz-112638 in Patients with G... 2015-10-06 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-016068-35 A randomized double blind-placebo controlled dose ranging study to evaluate the efficacy and safety of SAR153191 in patients with Ankylosing Spondylitis (AS) 2011-06-21 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-016091-80 Estudio multicentrico, randomizado, abierto, para evaluar el inhibidor de la poli (ADP-ribosa) polimerasa 1 (PARP-1), BSI-201, administrado una o dos veces por semana, en combinación con gemcitabina/c... 2013-05-29 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-016266-90 A randomized, double-blind, placebo-controlled, multicenter, two-part, dose ranging and confirmatory study with an operationally seamless design, evaluating efficacy and safety of SAR153191 on top of ... 2013-10-08 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-016568-36 Estudio aleatorizado, doble ciego y con triple simulación para comparar la eficacia de otamixabán con la de heparina no fraccionada más eptifibatida en pacientes con angina inestable/infarto de miocar... 2013-05-06 bad-data
Ongoing, reported early 2009-016707-30 A Phase 2 Study of XL147 in Subjects with Advanced or Recurrent Endometrial Carcinoma not-yet-due
Listed as ongoing, but also has a completion date and reported results 2009-016818-24 A Randomized, international, multi-center, open-label study to document optimal timing of initiation of dronedarone TreatmEnt after conversion with loading dose of aMIodarone in patients with perSiste... 2011-12-14 bad-data
Not reported 2009-016970-33 An Extension Protocol for Participants of Genzyme-Sponsored Prospective, Randomized, Open-Label, Parallel-Group, Multicenter Study of Matrix-Induced Autologous Chondrocyte Implantation (MACI® implant)... 2015-03-18 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-017270-21 Estudio aleatorizado de fase II de gemcitabina/cisplatino con o sin SAR240550 (BSI-201), un inhibidor de PARP1, en pacientes con cáncer de pulmón no microcítico en estadio IV _________________________... 2011-12-12 bad-data
Reported results 2009-017666-23 An open-label, randomized, two-arm parallel group study to compare the effects of 4-week QD treatment with lixisenatide or liraglutide on the postprandial plasma glucose in patients with type 2 diabet... 2010-11-18 due-trials
Completed, but no date, and reported results 2009-017688-40 Immunogenicity and Safety of the Influenza Vaccine (Split Virion, Inactivated), Northern Hemisphere 2010-2011 Formulation (Intradermal Route) bad-data
Ongoing, reported early 2009-017690-38 Immunogenicity and Safety of the Influenza Vaccine (Split Virion, Inactivated), Northern Hemisphere 2010-2011 Formulation (Intramuscular Route) not-yet-due
Reported results 2009-018172-33 A 24-week, open, multicenter, comparative study of 2 strategies (including insulin glargine versus premixed insulin) for the therapeutic management of patients with type 2 diabetes failing oral agents 2012-02-27 due-trials
Reported results 2009-018215-53 The effect of the addition of dronedarone to, versus increase of, existing conventional rate control medication on ventricular rate during paroxysmal or persistent atrial fibrillation (AFRODITE study) 2011-10-03 due-trials
Listed as ongoing, but also has a completion date and reported results 2010-018437-21 A 24-week, multicenter, international, randomized (1:1), parallel-group, open-label, comparative study of insulin glargine versus liraglutide in insulin-naïve patients with Type 2 diabetes treated wit... 2013-03-06 bad-data
Reported results 2010-018960-17 "Estudio de fase II, abierto, aleatorizado para evaluar la eficacia y seguridad de paclitaxel administrado semanalmente como agente único y dos regímenes diferentes de SAR240550 (BSI-201), un inhibido... 2017-02-28 due-trials
Completed, but no date, and reported results 2010-018976-25 An open label non-controlled trial to evaluate the effect of dronedarone (Multaq® 400 mg BID) on the quality of life in patiënts with a history of, or current non-permanent atrial fibrillation (AF) bad-data
Ongoing, reported early 2010-018991-25 Immunogenicity of the Intramuscular Inactivated, Split Virion Swine-origin A/H1N1 Influenza Vaccine Without Adjuvant in Healthy Adult Subjects not-yet-due
Listed as ongoing, but also has a completion date and reported results 2010-019247-19 A Randomized, international, multi-center, open-label study to document pharmacokinetics and optimal timing of initiation of dronedarone TreatmEnt following long-term aMIodarone in patients with parox... 2012-04-18 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-019255-22 Ensayo aleatorizado de Fase III de gemcitabina/carboplatino con o sin BSI-201 (SAR240550) (un inhibidor de PARP1) en pacientes con cáncer de pulmón no microcítico (CPNM) epidermoide en estadío IV no t... 2013-04-11 bad-data
Ongoing 2010-019262-86 A multi-center, uncontrolled extension study evaluating efficacy and safety of SAR153191 on top of DMARDs in patients with active Rheumatoid Arthritis (RA) not-yet-due
Listed as ongoing, but also has a completion date and reported results 2010-019263-11 A multicenter uncontrolled extension study evaluating the long term safety and efficacy of SAR153191 in patients with Ankylosing Spondylitis (AS) 2011-12-12 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-019340-40 A Phase 1/2 Combined Dose Ranging and Randomised, Open-label, Comparative Study of the Efficacy and Safety of Plerixafor in Addition to Standard Regimens for Mobilisation of Haematopoietic Stem Cells ... 2017-05-09 bad-data
Reported results 2010-019384-11 A multinational, randomized, double blind, controlled phase II trial of ombrabulin with taxane and platinum combination administered every three weeks, in first line treatment of patients with locally... 2012-10-02 due-trials
Listed as ongoing, but also has a completion date and reported results 2010-019791-73 A randomized, double blind, placebo controlled, parallel group trial for assessing the clinical benefit of Dronedarone 400mg BID on top of standard therapy in patients with permanent atrial fibrillati... 2011-11-21 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-019835-37 Safety and Immunogenicity of an Intramuscular H5N1 Inactivated, Split Virion Influenza Vaccine Adjuvanted with AF03 in Adults and Elderly subjects 2010-12-07 bad-data
Reported results 2010-020611-36 A Phase 4 Prospective Exploratory Muscle Biopsy, Biomarker, and Imaging Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa 2013-12-19 due-trials
Reported results 2010-021020-94 A randomized, double-blind, parallel-group, placebo- and active calibrator-controlled study assessing the clinical benefit of SAR153191 subcutaneous (SC) on top of methotrexate (MTX) in patients with ... 2011-09-15 due-trials
Listed as ongoing, but also has a completion date and reported results 2010-021128-92 Ensayo clínico multicéntrico, abierto y de un solo grupo para proporcionar acceso previo a la comercialización de cabazitaxel a los pacientes con cáncer de próstata metastásico hormono-resistente trat... 2015-12-21 bad-data
Completed, report not yet due 2010-021373-37 Evaluation of Insuman Implantable 400 IU/ml in patients with Type 1 diabetes treated with the Medtronic MiniMed Implantable Pump System using Insuplant 400 IU/mL 2018-02-01 not-yet-due
Ongoing, reported early 2010-022064-12 Estudio aleatorizado, abierto y multicéntrico de comparación de cabazitaxel a dosis de 25 mg/m2 y 20 mg/m2, administrado en combinación con prednisona cada 3 semanas, con docetaxel administrado en com... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2010-022163-35 Estudio aleatorizado, abierto y multicéntrico de comparación de cabazitaxel a dosis de 20 mg/m2 y 25 mg/m2 administrado cada 3 semanas en combinación con prednisona para el tratamiento del cáncer de p... 2015-08-19 bad-data
Completed, but no date 2010-022231-11 A Phase 3/4 Prospective Study to Characterize the Pharmacokinetics of bad-data
Reported results 2010-022596-64 A multinational, multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effect on cognitive performance, safety, and tolerability of SAR110894D at the doses of 0.5 mg, ... 2013-01-09 due-trials
Other 2010-023111-34 A Phase I/IIa Dose Escalation Safety Study of Subretinally Injected SAR422459, Administered to Patients with Stargardt's Macular Degeneration. not-yet-due
Listed as ongoing, but also has a completion date and reported results 2010-023172-12 A multi-center double-blind parallel-group placebo-controlled study of the efficacy and safety of teriflunomide in patients with relapsing multiple sclerosis who are treated with interferon-beta 2013-04-24 bad-data
Ongoing, reported early 2010-023400-28 ENSAYO CLÍNICO RANDOMIZADO FASE II DE DOCETAXEL-CARBOPLATINO EN COMBINACIÓN CON INIPARIB (BSI-201), Y DOCETAXEL-CARBOPLATINO COMO TRATAMIENTO NEOADYUVANTE DE PACIENTES CON CÁNCER DE MAMA ESTADIO TEMP... not-yet-due
Listed as ongoing, but also has a completion date 2010-023428-26 A Randomized, International, Open-Label, Multi-Centre, Phase III Study to Assess the Effect of a Patient Outreach Program on the Percentage of Time Patients with Locally Advanced or Metastatic Medulla... 2013-04-26 bad-data
Reported results 2010-023769-23 6-Month, Multicenter, Randomized, Open-label, Parallel-group Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine and Lantus® Both plus Mealtime Insulin in Patients with Ty... 2013-09-04 due-trials
Listed as ongoing, but also has a completion date and reported results 2010-023770-39 6-Month, Multicenter, Randomized, Open-label, Parallel-group Study Comparing the Efficacy and Safety of a New Formulation of Insulin glargine and Lantus® both in combination with oral antihyperglycemi... 2013-11-22 bad-data
Listed as ongoing, but also has a completion date 2010-023953-12 A Phase 2, Multi-Center, Randomized, Open-Label, Repeat Dose, Dose-Comparison Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Recombinant Human Acid Sphingomyelinase in Patients With A... 2015-03-31 bad-data
Reported results 2010-024631-16 A Phase 2, Multi-Center, Double-Blind, placebo controlled, Randomized Study of Ombrabulin in Patients with Platinum-Sensitive Recurrent Ovarian Cancer treated with Carboplatin/Paclitaxel 2014-07-09 due-trials
Reported results 2011-001160-21 Study to investigate the immune response to influenza vaccine in patients with multiple sclerosis on teriflunomide treatment and using a population of patients with multiple sclerosis as a reference 2012-01-23 due-trials
Reported results 2011-001424-38 A Randomized, Double-Blind, Active-Controlled, Parallel-Group Study to 2013-07-09 due-trials
Listed as ongoing, but also has a completion date 2011-001480-42 A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study followed by an Open-Label continuation Period to Assess the Safety and Efficacy of Two Different Regimens of Mipomersen in... 2016-03-15 bad-data
Ongoing, reported early 2011-001506-96 A Phase I/II Study of Cabazitaxel Combined with Abiraterone Acetate and Prednisone in Patients with Metastatic Castrate-Resistant Prostate Cancer (CRPC) whose Disease has Progressed after Docetaxel C... not-yet-due
Reported results 2011-001616-57 A Phase 2 study of SAR245409 in patients with relapsed or refractory mantle cell lymphoma, follicular lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma or diffuse large B-cell lymphoma 2014-09-12 due-trials
Ongoing, reported early 2011-001847-58 A Randomized Phase II, Open-Label study of the Efficacy and Safety of Orally Administered SAR302503 in patients with polycythemia vera (PV) or essential thrombocythemia (ET) who are resistant or intol... not-yet-due
Reported results 2011-001876-21 MULTINATIONAL, MULTICENTER, RANDOMIZED DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF EFFICACY AND SAFETY OF SAR292833 ADMINISTRATION FOR 4 WEEKS IN PATIENTS WITH CHRONIC PERIPHERAL NEUROPA... 2013-05-09 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-001897-25 A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study of SAR302503 in Patients with Intermediate-2 or High-Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis,... 2014-07-04 bad-data
Reported results 2011-001976-21 Safety and Immunogenicity of a Quadrivalent Influenza Vaccine Administered via the Intramuscular Route in Adult and Elderly Subjects 2012-06-11 due-trials
Reported results 2011-002090-36 A randomized, 24-week, open-label, 2-arm parallel-group, multicenter 2012-12-17 due-trials
Reported results 2011-002329-23 A 2-Week, Randomized, Placebo-Controlled, Fixed Dose Period Followed by a 6-Month, Single-Arm, Open-Label, Dose Titration Period Study to Investigate the Efficacy and Safety of Sevelamer Carbonate in ... 2015-06-16 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-002416-85 A 24-week, open-label, randomized, 2-arm parallel group, multinational, multi-center clinical trial to compare the efficacy and safety of lixisenatide injected prior to the main meal of the day versus... 2013-05-17 bad-data
Reported results 2011-002557-56 A randomized, double-blind, parallel-group, placebo-controlled study to assess the clinical benefit of SSR411298 as adjunctive treatment for persistent cancer pain 2012-03-27 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-002806-59 Long-term safety and tolerability of REGN727 / SAR236553 in high cardiovascular risk patients with hypercholesterolemia not adequately controlled with their lipid modifying therapy: a randomized, doub... 2015-01-16 bad-data
Completed, but no date, and reported results 2011-002865-39 An open label, multicenter phase II study of intravenous SAR3419, an anti-CD19 antibody-maytansine conjugate, in combination with rituximab in patients with relapsed or refractory Diffuse Large B Cell... bad-data
Completed, reported early 2011-003232-31 A two part protocol to assess, using double blind placebo control, the safety, tolerability, and pharmacokinetics of ascending single doses of a new intra-articular administration formulation of SAR11... 2013-05-02 not-yet-due
Listed as ongoing, but also has a completion date and reported results 2011-003415-31 Randomized Phase II Study of Cabazitaxel versus Topotecan in Small Cell Lung Cancer Patients with Progressive Disease during or after a First Line Platinum Based Chemotherapy 2014-03-13 bad-data
Listed as ongoing, but also has a completion date and reported results 2011-003538-16 A Randomized, Double-blind, Parallel, Placebo-controlled Study Assessing The Efficacy and Safety of Sarilumab Added To DMARD Therapy In Patients With Rheumatoid Arthritis Who Are Inadequate Responders... 2015-03-23 bad-data
Listed as ongoing, but also has a completion date 2011-003576-36 A Phase II Randomized Open Label Study of MM-121 in 2015-02-13 bad-data
Listed as ongoing, but also has a completion date and reported results 2011-003657-26 An open label non-randomized phase 2 study evaluating SAR3419, an anti-CD19 antibody – maytansine conjugate, administered as single agent by intravenous infusion to patients with relapsed or refractor... 2016-10-04 bad-data
No trial status on register 2011-004095-10 A Phase III Randomized, Open-Label, Active-Comparator Controlled bad-data
No trial status on register 2011-004108-39 A Phase III Randomized, Partially Double-Blind, Active- bad-data
Reported results 2011-004130-34 A Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of SAR236553/REGN727 Versus Ezetimibe in High Cardiovascular Risk Patients With Hypercholesterolemia Not Adequately... 2015-07-28 due-trials
No trial status on register 2011-004428-36 Phase III, A3L24 extension protocol, randomized, blind-observer, multi-center booster vaccination study in toddlers who completed a three-dose primary series of DTaP-IPV-Hep B-PRP-T combined vaccine o... bad-data
No trial status on register 2011-004431-31 Phase III, randomized, blind-observer, multi-center, four-arm, parallel-group trial in 2133 infants bad-data
No trial status on register 2011-004432-58 Phase III, open-label, and mono-center booster vaccination study in toddlers who completed a three-dose primary series of DTaP-IPV-Hep B-PRP-T combined vaccine or of Pentaxim™ and Engerix™ B in Study ... bad-data
No trial status on register 2011-004433-14 Randomized, open, controlled, multicenter, Phase III trial in infants who will receive DTaP-IPV-Hep B-PRP-T (Group 1, N=286), CombAct-Hib™ and Engerix B™ Pediatric with OPV (Group 2, N=286), or DTaP-I... bad-data
No trial status on register 2011-004434-33 Phase III, randomized, blind-observer, single-center, controlled trial of the DTaP-IPV-Hep B-PRP-T vaccine in 266 healthy Peruvian infants. bad-data
No trial status on register 2011-004449-42 Multi-center, randomized, observer blinded, Phase III trial in 1,376 infants, using Infanrix hexa™ as the control vaccine. Four-arm trial with subjects randomly allocated to receive 1 of 3 lots of DTa... bad-data
No trial status on register 2011-004450-26 Phase III, multi-center study in children fully vaccinated with a three-dose primary and the booster dose of the DTaP-IPV-Hep B-PRP-T combined vaccine or CombAct-Hib™ and OPV and Engerix™ B in Study A... bad-data
No trial status on register 2011-004451-39 Evaluation of Antibody Persistence at 3.5 and 4.5 Years of Age in Healthy Children After Primary Series and Booster Vaccination with Investigational (DTaP-IPV-HB-Hib) or Infanrix™ hexa vaccines in Lat... bad-data
No trial status on register 2011-004454-26 Mono-center, open-label, randomized, active-controlled trial in 310 infants bad-data
No trial status on register 2011-004455-39 Phase III, randomized, blind-observer, multicenter, four-arm study of three batches of the DTaP-IPV-Hep B-PRP-T vaccine and one arm receiving Infanrix hexa™. bad-data
No trial status on register 2011-004456-19 Phase III, open-label, multi-center booster vaccination study in toddlers who completed a three-dose primary series of the DTaP-IPV-Hep B-PRP-T combined vaccine or Infanrix hexa™ in Study A3L11. bad-data
No trial status on register 2011-004457-87 A Phase III, randomized, blind-observer, controlled, multicenter trial in 412 infants in Thailand. bad-data
Listed as ongoing, but also has a completion date and reported results 2011-004584-67 A randomized, double-blind, placebo controlled trial to assess safety, tolerability, pharmacokinetics and pharmacodynamics of lixisenatide in paediatric (10 - 17 years old) and adult patients with typ... 2014-03-04 bad-data
Ongoing 2011-004701-24 An International, Randomised, Double-Blind, Two-Arm Study To Evaluate The Safety And Efficacy Of Vandetanib 150 And 300mg/Day In Patients With Unresectable Locally Advanced Or Metastatic Medullary Thy... not-yet-due
Reported results 2011-004783-30 A pilot, exploratory, randomized, phase 2 safety study evaluating tumor cell (plasma cell) mobilization and apheresis product contamination in plerixafor plus non-pegylated G-CSF mobilized patients an... 2016-09-28 due-trials
No trial status on register 2011-005101-79 Safety and Immunogenicity of a Quadrivalent Influenza Vaccine bad-data
Listed as ongoing, but also has a completion date and reported results 2011-005109-56 A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of SAR236553/REGN727 in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately... 2014-12-05 bad-data
Listed as ongoing, but also has a completion date and reported results 2011-005155-14 An open-label, pharmacokinetic, pharmacodynamic, and tolerability study of AVE5026 administered at weight-adjusted doses to patients under 18 years of age with a Central Venous Line (CVL) 2012-06-26 bad-data
Listed as ongoing, but also has a completion date and reported results 2011-005226-21 A Phase II, Multicenter, Open Label, Single Arm Study of SAR302503 in Subjects Previously Treated with Ruxolitinib and with a Current Diagnosis of Intermediate-2 or High-Risk Primary Myelofibrosis, Po... 2014-04-29 bad-data
Ongoing 2011-005249-12 A two year, multicenter, randomized, double-blind, placebo-controlled, parallel group trial to evaluate efficacy, safety, tolerability, and pharmacokinetics of teriflunomide administered orally once d... not-yet-due
Reported results 2011-005374-33 Safety and Immunogenicity of the Quadrivalent Influenza Vaccine Administered via the Intramuscular Route in Children Aged 3 to 8 Years 2014-06-26 due-trials
Ongoing, reported early 2011-005595-42 A Phase 3/4, Prospective, Multinational, Open-label, Noninferiority Study of Alglucosidase Alfa Manufactured at the 160 L and 4000 L Scales in Treatment Naïve Patients with Infantile-Onset Pompe Disea... not-yet-due
Listed as ongoing, but also has a completion date 2011-005698-21 A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Alirocumab (SAR236553/REGN727) on the Occurrence of Cardiovascular Events in Patients Who Have Recently E... 2018-01-23 bad-data
Listed as ongoing, but also has a completion date and reported results 2011-005724-17 A Multicenter, Single arm, Open Label Clinical Trial to Evaluate the Safety and Health-Related Quality of Life of Aflibercept in Patients with Metastatic Colorectal Cancer (mCRC) Previously Treated wi... 2017-01-31 bad-data
Ongoing 2011-006140-78 International, multicenter, open-label, treatment-extension study for subjects who completed a Phase 1 or Phase 2 parental study to continue receiving treatment with SAR245408 or SAR245409 as a monoth... not-yet-due
Reported results 2011-006246-33 International, Multi-Center, Open-label, Treatment Extension Study of Iniparib as Monotherapy or in Combination Chemotherapeutic Regimens in Cancer Patients Who Have Derived Clinical Benefit From Inip... 2016-09-26 due-trials
Reported results 2012-000027-40 An open-label, randomized, three-parallel-group study on pharmacodynamic effects of 8-week QD treatment with lixisenatide compared to liraglutide in patients with type 2 diabetes not adequately contro... 2013-07-25 due-trials
Ongoing, reported early 2012-000048-89 A Multicenter, Single arm, Open Label Clinical Trial Evaluating Safety and Health-Related Quality of Life of Aflibercept in Combination with Irinotecan/5FU chemotherapy (FOLFIRI) in Patients with Met... not-yet-due
Reported results 2012-000146-35 6-Month, Multicenter, Randomized, Open-label, Parallel-group Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine and Lantus® in Insulin-Naïve Patients with Type 2 Diabetes... 2014-03-26 due-trials
Reported results 2012-001042-18 Booster Effect and Safety of a DTaP-IPV-Hib Combined Vaccine, with or without Hep B, in Healthy Subjects 11 to 18 Months of Age Who Received a Hexavalent or Hexavalent/Pentavalent Combined Vaccine dur... 2015-10-27 due-trials
Reported results 2012-001054-26 Immunogenicity and Safety Study of a Hexavalent DTaP-IPV-Hep B-PRP-T Combined Vaccine or Infanrix hexa™ Concomitantly Administered With 13-Valent Pneumococcal Conjugate Vaccine (PCV13), at 3, 5, 11 to... 2014-01-10 due-trials
Reported results 2012-001055-39 Phase III, multi-center trial in 795 infants in the Czech Republic, Germany, and Spain. Subjects from the Czech Republic and Germany will be randomized in Groups 1 and 2 to receive in a blind-observer... 2014-11-27 due-trials
Completed, but no date, and reported results 2012-001096-37 A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to evaluate the Efficacy and Safety of SAR236553 (REGN727) in Patients With Heterozygous Familial Hypercholesterolemia and LDL-C hi... bad-data
Ongoing, reported early 2012-001369-34 Double-blind, randomized, 8-week placebo-controlled and 16-week open label extension study investigating the Safety, Pharmacokinetics and Pharmacodynamics of SAR100842 Given Orally to Patients with Di... not-yet-due
Reported results 2012-001524-35 A 6-Month, Multicenter, Randomized, Open-label, Parallel-group Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine and Lantus® Injected in the Morning or Evening in Patien... 2014-03-14 due-trials
Ongoing, reported early 2012-001966-14 A Cross-sectional Study of Renal Function in Treatment-naïve, Young Male Patients with Fabry Disease not-yet-due
Listed as ongoing, but also has a completion date and reported results 2012-001984-66 A Randomized, Controlled Study of Sarilumab and Methotrexate (MTX) Versus Etanercept and MTX in Patients with Rheumatoid Arthritis (RA) and an Inadequate Response to 4 Months of Treatment with Adalimu... 2015-01-12 bad-data
Reported results 2012-002013-19 A randomized, double-blind, placebo-controlled, multicenter study evaluating efficacy and safety of SAR339658 in patients with active moderate to severe Ulcerative Colitis (UC). 2014-05-20 due-trials
Reported results 2012-002365-35 A Phase 2, Multicenter, Double-Blind, Parallel Dosing, Randomized Study of Fresolimumab or Placebo in Patients with Steroid-Resistant Primary Focal Segmental Glomerulosclerosis 2015-01-27 due-trials
Ongoing, reported early 2012-002961-36 Phase II two stage dose finding run-in study of SAR3419, an anti-CD19 antibody-maytansine conjugate,administered as a single agent by intravenous infusion in patients with relapsed or Refractory Acute... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2012-003292-19 A randomized, double-blind, placebo-controlled, 2-arm parallel-group, multicenter, 24 week study assessing the safety and efficacy of lixisenatide in older patients with type 2 diabetes inadequately c... 2015-02-19 bad-data
Listed as ongoing, but also has a completion date and reported results 2012-003536-23 A Randomized, Double-Blind, Double-Dummy Study Assessing The Safety and Tolerability of Sarilumab and Tocilizumab In Patients With Rheumatoid Arthritis Who Are Inadequate Responders to or Intolerant o... 2014-10-14 bad-data
Listed as ongoing, but also has a completion date and reported results 2012-004096-38 A randomized, open-label, active-controlled, 3-arm parallel-group, 26-week study comparing the efficacy and safety of lixisenatide to that of insulin glulisine once daily and insulin glulisine three t... 2015-12-23 bad-data
Reported results 2012-004339-21 A Multicenter, Randomized, Open-Label, Parallel-Group Usability Study Of The Sarilumab Auto-Injector Device And A Prefilled Syringe In Patients With Moderate To Severe Active Rheumatoid Arthritis Who ... 2016-03-11 due-trials
Reported results 2012-004845-34 A Randomized, Double-Masked and Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sarilumab Administered Subcutaneously Every 2 Weeks in Patients with Non-Infectious, Intermediate, Poste... 2016-04-19 due-trials
Completed, but no date, and reported results 2012-005243-25 Immunogenicity and Safety of the Trivalent Influenza Vaccine (Split-Virion, Inactivated), Northern Hemisphere 2013-2014 Formulation (Intradermal Route) bad-data
Reported results 2012-005324-16 Exploratory Open Label Study to Investigate the Effect of Teriflunomide on Immune Cell Subsets in the Blood of Patients With Relapsing Forms of Multiple Sclerosis 2015-01-22 due-trials
Ongoing 2013-000051-40 A long-term study to assess the ongoing safety and efficacy of olipudase alfa in patients with acid sphingomyelinase deficiency not-yet-due
Ongoing 2013-000420-34 Etude de phase IV, de non infériorité, multicentrique, randomisée, en double aveugle, comparant la pristinamycine (2g x 2 par jour pendant 2 jours puis 1g x 3 par jour pendant 5 à 7 jours) à l’amoxici... not-yet-due
Ongoing 2013-000422-58 A Randomised, Double-Blind, Placebo-Controlled, Multi-Centre Phase III Study to Assess the Efficacy and Safety of Vandetanib (CAPRELSA™) 300 mg in Patients with Differentiated Thyroid Cancer That Is E... not-yet-due
Listed as ongoing, but also has a completion date 2013-000775-32 Efficacy, Immunogenicity, and Safety Study of Clostridium difficile Toxoid Vaccine in Subjects at Risk for C. difficile Infection 2018-06-12 bad-data
Reported results 2013-000856-16 A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients with Moderate to Severe Uncontrolled Asthma 2015-04-08 due-trials
Completed, but no date, and reported results 2013-000858-22 A Single-Arm, Open Label Study of Aflibercept as Maintenance Therapy Following Induction with Aflibercept in Combination with XELOX, as First-Line Treatment for Metastatic Colorectal Cancer Patient bad-data
Reported results 2013-001012-30 A Multicenter Single-Arm Open Label Extension Study Evaluating The Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC) 2014-05-08 due-trials
Listed as ongoing, but also has a completion date and reported results 2013-001231-51 Efficacy and Immunogenicity Study of Quadrivalent Influenza Vaccine Administered via the Intramuscular Route in Healthy Children Aged 6 to 35 Months 2016-07-27 bad-data
Ongoing 2013-001418-13 A Phase 1/2 Dose Escalation Safety, Pharmacokinetic and Efficacy Study of Multiple Intravenous Administrations of a Humanized Monoclonal Antibody (SAR650984) Against CD38 In Patients with Selected CD3... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2013-001439-34 A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (... 2015-11-19 bad-data
Reported results 2013-001803-35 A Randomized, Double-Blind, Phase 2, Placebo Controlled, 2 Arm Study To Evaluate Dupilumab In Patients With Bilateral Nasal Polyposis And Chronic Symptoms Of Sinusitis 2014-12-05 due-trials
Listed as ongoing, but also has a completion date and reported results 2013-002572-40 Open-Label Extension Study of EFC12492, R727-CL-1112, EFC12732 and LTS11717 Studies to Assess the Long-Term Safety and Efficacy of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemi... 2017-06-30 bad-data
Reported results 2013-002659-14 A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy and Safety of Alirocumab in Patients with Primary Hypercholesterolemia Not Treated With a Statin 2017-06-30 due-trials
Reported results 2013-002790-22 An open-label, randomized, parallel group study assessing the immunogenicity and safety of sarilumab administered as monotherapy in patients with active rheumatoid arthritis 2015-05-26 due-trials
Reported results 2013-002945-12 Six-month, Randomized, Open-label, Parallel-group Comparison of SAR342434 to Humalog® in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine, with a 6-month Safety Extension Perio... 2016-07-01 due-trials
Reported results 2013-003131-30 A randomized, 30 week, active-controlled, open-label, 3-treatment arm, parallel-group multicenter study comparing the efficacy and safety of insulin glargine/ lixisenatide fixed ratio combination to i... 2015-06-17 due-trials
Listed as ongoing, but also has a completion date and reported results 2013-003132-79 A randomized, 30-week, active-controlled, open label, 2-treatment arm, parallel-group, multicenter study comparing the efficacy and safety of the insulin glargine/lixisenatide fixed ratio combination ... 2015-07-09 bad-data
Reported results 2013-003267-55 An international, multicenter, open-label, one-arm study in 150 infants vaccinated with a 3-dose primary series of the DTaP-IPV-Hep B-PRP-T combined vaccine in the Russian Federation and Poland. 2016-08-29 due-trials
Ongoing 2013-003321-28 An open-label, multicenter, multinational extension study of the long-term safety and pharmacokinetics of repeated biweekly infusions of neoGAA in patients with Pompe disease not-yet-due
Other 2013-003856-19 Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Dupilumab in Patients With Asthma Who Participated in a Previous Dupilumab Asthma Clinical Study not-yet-due
Ongoing 2013-003884-71 A long-term follow-up study for Multiple Sclerosis patients who have completed the alemtuzumab Extension Study (CAMMS03409) not-yet-due
Reported results 2013-005324-41 A Phase 2 Study to Evaluate the Safety, Pharmacodynamics, Pharmacokinetics, and Exploratory Efficacy of GZ/SAR402671 in Enzyme Replacement Therapy (ERT) Treatment-naïve Adult Male Patients Diagnosed w... 2016-09-06 due-trials
Listed as ongoing, but also has a completion date and reported results 2014-000092-62 Single arm study to assess comprehensive infusion guidance for the management of the infusion associated reaction (IARs) in Relapsing-Remitting Multiple Sclerosis (RRMS) patients treated with Lemtrada... 2016-04-01 bad-data
Reported results 2014-000785-21 Immunogenicity and Lot-to-Lot Consistency Study of a Quadrivalent Influenza Vaccine in Adult and Elderly Subjects 2015-10-23 due-trials
Reported results 2014-001253-16 A multi-center, open-label, single-arm, multiple dose study with HOE901-U300 to assess the Ease of Use and Safety of a new U300 pen injector in insulin-naïve patients with T2DM 2014-11-20 due-trials
No trial status on register 2014-001534-29 Safety of ChimeriVax™ Dengue Tetravalent Vaccine in Subjects Aged 2 to 45 Years in the Philippines bad-data
Reported results 2014-001643-20 A Phase 2a/2b Double-Blind, Randomized, Placebo-Controlled Study Assessing Efficacy, Safety, and Dose-Response of Vatelizumab in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS) 2016-07-07 due-trials
No trial status on register 2014-001694-14 A Study of Dengue Vaccine in Healthy Toddlers Aged 12 to 15 Months in the Philippines bad-data
No trial status on register 2014-001706-17 Safety of ChimeriVax™ Dengue Tetravalent Vaccine in Subjects Aged 2 to 45 Years in Mexico bad-data
No trial status on register 2014-001707-53 Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin America bad-data
No trial status on register 2014-001708-24 Efficacy and Safety of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 Years in Asia bad-data
No trial status on register 2014-001709-41 Immunogenicity and Safety of Tetravalent Dengue Vaccine in Healthy Subjects Aged 2 to 45 Years in Viet Nam bad-data
No trial status on register 2014-001710-25 Efficacy and Safety of Dengue Vaccine in Healthy Children Aged 4 to 11 Years in Thailand bad-data
No trial status on register 2014-001711-40 Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 Years bad-data
No trial status on register 2014-001713-26 Immunogenicity and Large-Scale Safety of Tetravalent Dengue Vaccine in Healthy Subjects Aged 2 to 45 Years in Singapore bad-data
No trial status on register 2014-001714-26 Immunogenicity and Safety of Yellow Fever Vaccine (Stamaril®) Administered Concomitantly with Tetravalent Dengue Vaccine in Healthy Toddlers at 12-13 Months of Age in Colombia and Peru bad-data
No trial status on register 2014-001715-39 Study of CYD Dengue Vaccine in Healthy Children and Adolescents in South America bad-data
No trial status on register 2014-001716-19 Efficacy and Safety of a Novel Tetravalent Dengue Vaccine in Healthy Children and Adolescents Aged 9 to 16 Years in Latin America bad-data
No trial status on register 2014-001717-11 Study of a Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 11 Years in Malaysia bad-data
No trial status on register 2014-001736-11 Immunogenicity and Safety of a Booster Injection of DTaP-IPV//Hib (Pentaxim™) Administered Concomitantly with Tetravalent Dengue Vaccine in Healthy Toddlers Aged 15 to 18 Months in Mexico bad-data
No trial status on register 2014-001737-88 Long-Term Safety Follow-Up of Thai Children Who Were Included in an Efficacy Study of a Tetravalent Dengue Vaccine bad-data
Completed, but no date, and reported results 2014-002263-15 Effects of GLP-1 Receptor Agonist Lixisenatide on Post-prandial Lipid Profile in Obese Type 2 Diabetic Patients bad-data
Listed as ongoing, but also has a completion date and reported results 2014-002399-10 A Randomized, Open-label, 2-arm Parallel-group, Multicenter, 26-week Study Assessing the Safety and Efficacy of H0E901-U300 Versus Lantus in Older Patients with Type 2 Diabetes Inadequately Controlled... 2016-05-20 bad-data
Listed as ongoing, but also has a completion date 2014-002541-22 A randomized, double-blind, parallel-group study assessing the efficacy and safety of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis 2017-12-29 bad-data
Ongoing 2014-002550-39 A 52-week two-part, open-label, multicenter, multinational study of the safety, tolerability, pharmacokinetics, pharmacodynamics, and exploratory efficacy of GZ/SAR402671 in combination with Cerezyme ... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2014-002844-42 Six-month, Randomized, Open-label, Parallel-group Comparison of the Insulin Analog SAR342434 to Humalog® in Adult Patients With Type 2 Diabetes Mellitus also Using Insulin Glargine 2016-02-16 bad-data
No trial status on register 2014-002867-13 Multinational, randomized, double blind, double dummy, pharmacokinetic study of telithromycin oral suspension (25 mg/kg once daily for 7-10 days), with secondary assessments of safety relative to azit... bad-data
Ongoing 2014-003198-40 A phase 1/2, multi-center, open-label, ascending dose study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and exploratory efficacy of olipudase alfa in pediatric patients Ag... not-yet-due
Reported results 2014-003265-19 A Long-Term Follow-up Study Assessing the Safety and Efficacy of Vatelizumab in Multiple Sclerosis (MS) Patients Who Completed Treatment in Study DRI13839 2016-07-07 due-trials
Listed as ongoing, but also has a completion date 2014-003933-24 Efficacy and Safety of SAR156597 in the Treatment of Idiopathic Pulmonary Fibrosis (IPF): A Randomized, Double-blind, Placebo-controlled, 52-week Dose-ranging Study 2017-08-14 bad-data
No trial status on register 2014-003989-24 Program of Rasburicase in the Treatment of Hyperuricemia in Children and Adolescent Patients With or at Risk of Tumor Lysis Syndrome bad-data
No trial status on register 2014-004002-15 Local, Phase IV, Multicenter, Double-blind, Randomized, Parallel, With Two Treatment Arms, Placebo-controlled Study to Evaluate the Reduction of Inflammatory Symptoms in the Treatment of Bacterial Pha... bad-data
Completed, but no date, and reported results 2014-004367-20 A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccines in Healthy Toddlers bad-data
Ongoing, reported early 2014-004533-13 A 21-Week, Open-label, Randomized, Controlled, Parallel-group, Multi-center Study Evaluating the Efficacy and Safety of HOE901-U300 Administered According to a Device-Supported Treat-to-target Regimen... not-yet-due
No trial status on register 2014-004628-23 Comparison of Teicoplanin and Vancomycin in Terms of Efficacy and Side Effect Profile During Initial Antibiotic Treatment of Febrile Neutropenic Patients at High Risk For Gram-Positive Infection: Mult... bad-data
No trial status on register 2014-004629-42 Bacillus Clausii in Preventing Antibiotic-Associated Diarrhea Among Filipino Infant and Children: A Multi-Center, Randomized, Open-Label Controlled (Treatment vs No Treatment) Clinical Trial of Effica... bad-data
No trial status on register 2014-004630-26 Multinational, Randomized, Double-Blind, Double Dummy, Comparative Study to Evaluate the Efficacy and Safety of 5 Days Telithromycin 25mg/kg od Versus 10 Days Penicillin V 13.3 mg/kg Tid in Children 6... bad-data
No trial status on register 2014-004631-39 Multinational, randomized, double blind, comparative study to evaluate the efficacy and safety of telithromycin, 800 mg once daily for 5 days, versus penicillin V, 500 mg three times daily for 10 days... bad-data
No trial status on register 2014-004636-19 Phase III Comparative Study to Assess the Efficacy and Safety of Oral Rehydration Therapy (ORT) in Combination With Spores of Bacillus Clausii (Enterogermina)Versus ORT Alone, Administered for 5 Days ... bad-data
No trial status on register 2014-004637-47 Multinational, Randomized, Double-Blind, Double-Dummy, Comparative Study to Evaluate the Efficacy and Safety of 5 Days Telithromycin 25mg/kg od Versus 5 Days Azithromycin 10 mg/kg od Followed by 5 mg/... bad-data
No trial status on register 2014-004639-38 A study of effectiveness and safety of Apidra in combination with Lantus therapy in basal-bolus insulin regimen in inadequately controlled children and adolescents with Type 1 diabetes in the Russian ... bad-data
No trial status on register 2014-004640-35 A 24-week, Randomized, Open-label, Parallel Group, Multicenter Comparison of Lantus® (Insulin Glargine) Given Once Daily Versus Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabete... bad-data
No trial status on register 2014-004643-12 Post-marketing study of Amaryl® (Glimepiride) in patients with type 2 diabetes to investigate pediatric and adult population pharmacokinetics [multicenter, non-comparative, 12-28 weeks, non-blind titr... bad-data
No trial status on register 2014-004644-35 Single dose, open label safety, tolerability, pharmacokinetic and pharmacodynamic evaluation of three different eplivanserin doses in children aged 6-17 years with insomnia of various origins bad-data
No trial status on register 2014-004645-27 A randomized, multicenter, double-blind, placebo-controlled, parallel group study of the 12 month effect of treatment with once daily triamcinolone acetonide (NASACORT® AQ Nasal Spray 110 μg) on the g... bad-data
No trial status on register 2014-004646-98 A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Evaluating the Pharmacodynamic Effect of a 6-week Treatment With Triamcinolone Acetonide Aqueous Nasal Spray 110 μg an... bad-data
No trial status on register 2014-004659-30 Four-week, open-label, multicenter, randomized, parallel-group study to investigate the pharmacokinetics, safety, tolerability and the effects on leak point pressure of 2 oral doses of alfuzosin (0.1 ... bad-data
No trial status on register 2014-004660-37 Monocentric Study, Phase III, for Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Tina Gel Sweet Flower bad-data
No trial status on register 2014-004661-25 Monocentric Study, Phase III, for Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Tina Gel Tangerina Mix bad-data
No trial status on register 2014-004662-26 Safety Dermatological Evaluation: genital Mucosa Irritation - Product bad-data
No trial status on register 2014-004663-20 Safety Dermatological Evaluation: genital mucosa irritation - Product tested: Dermacyd PH_DETINBACK Sweet Flower bad-data
No trial status on register 2014-004664-38 Safety Dermatological Evaluation: genital mucosa irritation - Product tested: Dermacyd PH_DETINLYN Tangerine Mix. bad-data
No trial status on register 2014-004665-24 Safety Dermatological Evaluation: genital mucosa irritation - Product tested: Dermacyd PH_DETINBACK Tangerine Mix. bad-data
No trial status on register 2014-004666-14 Safety Dermatological Evaluation: acceptability with pediatric follow up – Dermacyd Infantile LACAC_L_04678 bad-data
Ongoing 2014-004676-29 A Randomized, Open Label, Multicenter Study of Cabazitaxel Versus an Androgen Receptor (AR)- not-yet-due
Completed, but no date 2014-004805-34 A Two Part Protocol Using Double Blind Placebo Control to Assess the Safety, Tolerability, and Pharmacokinetics of Single Escalating Intra-articular Doses Followed by Assessment of Efficacy, Safety, T... bad-data
Ongoing 2014-004850-32 A 26-week open-label study assessing the efficacy and safety of the insulin glargine/lixisenatide fixed ratio combination in adults with Type 2 Diabetes inadequately controlled on GLP-1 receptor agoni... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2014-004940-36 A Randomized, Double Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in Patients with Persistent Asthma 2017-11-23 bad-data
Listed as ongoing, but also has a completion date and reported results 2014-005047-40 A Randomized, Double Blind, Single Dose, Crossover Study, in Subjects with Mild to Moderate Asthma, to Compare the Pharmacodynamic (Bronchodilator) Responses of 12.5/250 µg and 50/250 µg Salmeterol / ... 2015-08-25 bad-data
Listed as ongoing, but also has a completion date and reported results 2014-005696-93 Phase II, Open Label, Single Arm Study Assessing the Clinical Benefit of SAR125844, Administered as Single Agent by Weekly Intravenous (IV) Infusion, for the Treatment of Patients with Advanced Pretre... 2016-01-05 bad-data
Ongoing 2015-000371-26 A phase 2/3, multicenter, randomized, double-blinded, placebo-controlled, repeatdose, dose-comparison study to evaluate the efficacy, safety, pharmacodynamics, and pharmacokinetics of olipudase alfa i... not-yet-due
Ongoing 2015-000479-28 A Phase II Open Label Study of Sargramostim Among Patients Receiving Myelosuppressive Induction Chemotherapy for Acute Myelogenous Leukemia not-yet-due
No trial status on register 2015-000512-18 A Phase 4 Open Label, Prospective Study in Patients With Pompe Disease to Evaluate The Efficacy and Safety of Alglucosidase Alfa Produced at the 4000L Scale bad-data
No trial status on register 2015-000582-31 An Exploratory, Open-Label Study of the Safety and Efficacy of High Dose or High Dosing Frequency Myozyme® (alglucosidase alfa) Treatment in Patients with Pompe Disease Who Do Not Have an Optimal Resp... bad-data
No trial status on register 2015-000583-34 An Exploratory Study of the Safety and Efficacy of Immune Tolerance Induction (ITI) in Patients with Pompe Disease Who Have Previously Received Myozyme bad-data
No trial status on register 2015-000584-14 An Exploratory Study of the Safety and Efficacy of Prophylactic Immunomodulatory Treatment in Myozyme-naïve CRIM(-) Patients with Infantile-Onset Pompe Disease bad-data
No trial status on register 2015-000585-61 A Multicenter, Multinational, Open-Label Study of Anti-Laronidase Antibody Formation and Urinary GAG Levels in Patients with Mucopolysaccaridosis I (MPS I) Being Treated with Aldurazyme® (laronidase) bad-data
Ongoing 2015-000620-28 A Multi-Country, Multicenter, Single-Arm, Open-Label Study to Document the Safety, Tolerability and Effect of Alirocumab on atherogenic lipoproteins in High Cardio-Vascular Risk Patients With Severe H... not-yet-due
No trial status on register 2015-000697-35 Evaluation of Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta (The INFORM Study) bad-data
Listed as ongoing, but also has a completion date and reported results 2015-000799-92 A randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of Alirocumab in insulin treated patients with type 1 or type 2 diabetes and with hypercholeste... 2017-04-03 bad-data
Completed, but no date 2015-001167-39 Studio nazionale, randomizzato, controllato, in aperto, a gruppi paralleli per confrontare l’efficacia e la sicurezza di due diversi approcci con algoritmo di titolazione (gestito dal medico vs gestit... bad-data
No trial status on register 2015-001172-21 A Phase 1, Open-label, Multi-center Study of Clofarabine in Japanese Pediatric Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia bad-data
No trial status on register 2015-001173-41 An Open-Label, Multi-Center Safety and Tolerability Pilot Combination Study of Clofarabine, Etoposide, Cyclophosphamide, PEG-asparaginase, and Vincristine in Pediatric Patients with Acute Lymphoblasti... bad-data
No trial status on register 2015-001174-18 A Phase I/II Dose-Escalation Study of Clofarabine in Combination with Etoposide and Cyclophosphamide in Pediatric Patients with Refractory or Relapsed Acute Leukemias bad-data
Completed, but no date 2015-001186-46 A 28-week, prospective, single-arm, open label phase 4 study to evaluate treatment optimization with once-daily insulin glargine HOE901-300 IU/ml in combination with prandial rapid-acting insulin anal... bad-data
No trial status on register 2015-001245-89 Relative bioavailability study between 75 mg tablet and 75 mg solution of Clopidogrel (SR25990C) after single oral administration to young healthy men. Open, crossover, randomized and monocenter study bad-data
Ongoing 2015-001314-10 A Randomized, Double-blind, 52-week, Placebo Controlled Efficacy and Safety Study of Dupilumab, in Patients with Bilateral Nasal Polyposis on a Background Therapy with Intranasal Corticosteroids not-yet-due
Other 2015-001395-21 An Open-label Extension Study of Subcutaneously Administered ALN-AT3SC in Patients with Moderate or Severe Hemophilia A or B who have Participated in a Previous Clinical Study with ALN-AT3SC not-yet-due
Listed as ongoing, but also has a completion date 2015-001572-22 An exploratory, randomized, double-blind, placebo-controlled study of the effects of dupilumab on airway inflammation of adults with persistent asthma 2018-01-03 bad-data
Listed as ongoing, but also has a completion date and reported results 2015-001573-40 A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dupilumab in Patients with Severe Steroid Dependent Asthma 2017-11-13 bad-data
Listed as ongoing, but also has a completion date and reported results 2015-001626-42 A 24-Week, Multicenter, Randomized, Open-Label, 2-Arm Parallel-group Study Evaluating the Efficacy and Safety of Patient- Versus Physician-managed Titration of Insulin Glargine U300 in Type 2 Diabetes... 2017-06-02 bad-data
Completed, report not yet due 2015-001831-18 A twenty six week, randomized, open-label, 2-arm parallel group real world pragmatic trial to assess the clinical and health outcomes benefit of Toujeo® compared to standard of care insulin for initia... 2017-10-16 not-yet-due
Completed, report not yet due 2015-001832-39 A twenty-six week, randomized, open-label, 2-arm parallel group real world pragmatic trial to assess the clinical and health outcomes benefit of transition to Toujeo compared to standard of care insul... 2017-10-20 not-yet-due
Listed as ongoing, but also has a completion date and reported results 2015-001934-19 A Randomized, Open-Label, Parallel Group Study to Evaluate the Efficacy and Safety of Alirocumab Versus Usual Care in Patients with Type 2 Diabetes and Mixed Dyslipidemia at High Cardiovascular Risk w... 2017-05-18 bad-data
Ongoing 2015-002084-42 6-Month, Multicenter, Randomized, Open-label, 2-Arm, Parallel-group Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine and Lantus® Injected Once Daily in Children and Ado... not-yet-due
No trial status on register 2015-002184-42 A Phase 1-2 Dose Finding, Safety and Efficacy Study of Cabazitaxel in bad-data
Completed, report not yet due 2015-002416-33 An interventional, Open-label, single-arm, multicenter, 24 Weeks phase 4 study assessing the Efficacy and Safety of Toujeo in patients with Type 2 Diabetes inadequately controlled with Basal Insulin... 2017-07-24 not-yet-due
Ongoing 2015-003101-42 A randomized, 24-week treatment, double-blind, placebo-controlled efficacy and not-yet-due
No trial status on register 2015-003190-14 Safety of Two Doses of Avaxim® 80U Pediatric (Inactivated Hepatitis A vaccine) Administered 6 Months Apart in Healthy Toddlers, Children and Adolescents Aged 12 Months to 15 Years in China bad-data
No trial status on register 2015-003203-30 Immunogenicity and Safety of the Purified Vero Rabies Vaccine- Serum Free (VRVg) in Comparison with the Human Diploid Cell Vaccine, IMOVAX® Rabies in a Pre-exposure Prophylaxis Regimen in Healthy Chil... bad-data
No trial status on register 2015-003279-31 Immunogenicity and Safety of IMOVAX POLIO® Subcutaneous as a Booster Given in Pre-school Age Children in Japan (IPV46) bad-data
No trial status on register 2015-003500-23 Safety and Immunogenicity of Tdap Vaccine Compared to DTaP vaccine bad-data
Completed, but no date, and reported results 2015-003749-24 Effects of MagneB6® (470.0 mg Magnesium Lactate Dihydrate + 5.0 mg Pyridoxine Hydrochloride, Coated Tablet) Supplementation (8 Weeks) on Stress Levels of Chronically Stressed Subjects, with Suboptimal... bad-data
Other 2015-003766-85 An 8-Week Open-Label, Sequential, Repeated Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents with Heterozygous Familial Hypercholesterolemia Followed by ... not-yet-due
No trial status on register 2015-003914-25 Clinical Safety Study of the Tdap Combined Vaccine (ADACEL) as a Booster Dose in Healthy Adults and Children in China bad-data
No trial status on register 2015-003941-24 Immunogenicity and Safety of Sanofi Pasteur’s Tdap Combined Vaccine (ADACEL) as a Booster Dose, versus Local DT Vaccine in Healthy Children or versus Local Td Vaccine in Healthy Adolescents and Adults... bad-data
No trial status on register 2015-003950-41 Immunogenicity and safety of the tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed (SP306) given intramuscularly compared to Diphtheria and Tetanus toxoids adsorbed (D... bad-data
Other 2015-003999-79 An Open-label, Sequential, Ascending, Repeated Dose-finding Study of Sarilumab, Administered with Subcutaneous (SC) Injection, in Children and Adolescents, Aged 2 to 17 Years, with Polyarticular-cours... not-yet-due
Ongoing 2015-004000-35 An Open-label, Sequential, Ascending, Repeated Dose-finding Study of Sarilumab, Administered with Subcutaneous (SC) Injection, in Children and Adolescents, Aged 1 to 17 Years, with Systemic Juvenile I... not-yet-due
Completed, report not yet due 2015-004715-20 Phase IV study to evaluate the safety and efficacy of the treatment of hyperglycemia with Gla-300 in basal-bolus regimen in hospitalised T2D patients poorly controlled with basal insulin and/or non-in... 2018-07-17 not-yet-due
Reported results 2015-004843-38 A Randomized, Double-blind, 2x2 Cross-over Euglycemic Clamp Study in Two Parallel Cohorts to Compare the Pharmacodynamic and Pharmacokinetic Properties of 0.4 and 0.6 U/kg/day Insulin Glargine (Toujeo... 2016-07-09 due-trials
Listed as ongoing, but also has a completion date 2015-005101-36 A 24-Week, Multicenter, Randomized, Open-label, Parallel-group Study Comparing the Efficacy and Safety of Toujeo® and Tresiba® in Insulin-Naive Patients with Type 2 Diabetes Mellitus Not Adequately Co... 2017-08-15 bad-data
No trial status on register 2015-005181-33 Safety and Immunogenicity Study for Use of Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (Menactra®) versus Tetanus Toxoid, Reduced Diphtheria Toxoid and ... bad-data
No trial status on register 2015-005182-23 Immunogenicity and Safety of the Inactivated Poliomyelitis Vaccine (IMOVAX Polio™) Administered at 2, 3, and 4 Months of Age and Followed by a Booster Dose at 18 Months of age in Healthy Infants in Ch... bad-data
No trial status on register 2015-005183-42 Immunogenicity and Safety of Fractional Doses of Sanofi Pasteur’s Inactivated Poliomyelitis Vaccine (IMOVAX Polio™) Administered Intradermally versus Full Doses of Inactivated Poliomyelitis Vaccine (I... bad-data
No trial status on register 2015-005184-16 Immunogenicity and Safety of Fractional Booster Dose of sanofi pasteur’s Inactivated Poliomyelitis Vaccine (IMOVAX Polio) Administered Intradermally versus Full Booster Dose of Inactivated Poliomyelit... bad-data
No trial status on register 2015-005185-34 Safety study of IMOVAX Polio in selected cities in China, an observational post marketing study bad-data
No trial status on register 2015-005186-23 Large scale safety study of IMOVAX Polio in selected cities in China, an observational post marketing study bad-data
No trial status on register 2015-005187-42 Immunogenicity and Safety of the SP059 Given Subcutaneously as a Three-Dose Primary and Booster Vaccination in Infants in Japan bad-data
No trial status on register 2015-005188-17 Immunogenicity and Safety of different sequential schedules of Inactivated Poliomyelitis Vaccine (IMOVAX Polio®) followed by Oral Poliomyelitis Vaccine in Healthy Infants in China versus Oral Poliomye... bad-data
No trial status on register 2015-005189-48 Safety and Immunogenicity of Sanofi Pasteur Meningococcal (Groups A and C) Polysaccharide Vaccine versus Lanzhou Institute of Biological Products Meningococcal (Groups A and C) Polysaccharide Vaccine ... bad-data
No trial status on register 2015-005190-21 Immunogenicity and Safety of ADACEL Polio (TdcP-IPV Vaccine) Administered at 6 to 8 Years of Age as a Fifth Dose (Pre-School Booster) in Healthy Children in Taiwan bad-data
No trial status on register 2015-005191-18 Immunogenicity and Safety of Sanofi Pasteur’s AVAXIM 80U Pediatric Vaccine Administered in Healthy Adolescents, Children and Toddlers in People’s Republic of China Followed by a Booster Dose 6 Months ... bad-data
No trial status on register 2015-005192-24 Immunogenicity and Safety of AVAXIM™ 80U-Pediatric Administered Alone or Concomitantly with TRIMOVAX™ in 12-13 Months old Healthy Hepatitis A Seronegative Turkish Children bad-data
No trial status on register 2015-005193-38 A Controlled Study of the Safety and Immunogenicity of ChimeriVax™ Japanese Encephalitis Vaccine in Thai Toddlers and Children bad-data
No trial status on register 2015-005194-20 Immunogenicity and Safety of the Purified Vero Rabies Vaccine - Serum Free in Comparison with the Reference Purified Vero Rabies Vaccine in Post-exposure Use in Healthy Subjects in China bad-data
No trial status on register 2015-005195-22 Immunogenicity and Safety of a Single Dose of SP093 Typhoid Vi Polysaccharide Vaccine Given in Japanese Subjects bad-data
No trial status on register 2015-005196-24 Three-, Five-, and Ten-Year Data on the Long-Term Immunogenicity of Tetanus and Diphtheria Toxoids Adsorbed Combined with Component Pertussis Vaccine and Inactivated Poliomyelitis Vaccine (TdcP-IPV) i... bad-data
No trial status on register 2015-005197-38 Six-Month, One-Year, Three-Year, Five-Year and Ten-Year Data on the Long-Term Immunogenicity of Td-mIPV, Tdap-vIPV, Td, aP and Tdap in Adolescents and Adults bad-data
No trial status on register 2015-005293-38 Immunogenicity and Safety of the sanofi pasteur’s DTacP-IPV//PRP~T Combined Vaccine (PENTAXIM™) versus sanofi pasteur’s DTacP-IPV Combined Vaccine (TETRAXIM™) given simultaneously at separate sites wi... bad-data
No trial status on register 2015-005337-45 Immunogenicity and Safety of a Booster Dose of Polysaccharide Pneumococcal vaccine (Pneumo 23®) in 12 to 18 Months-Old Children Primed with Three Doses of Pneumococcal Conjugate Vaccine (Prevnar®) in ... bad-data
No trial status on register 2015-005348-33 Immunogenicity and safety of Sanofi Pasteur’s DTaP-IPV combined vaccine (TETRAXIM™) given as a three-dose primary vaccination in South Korean healthy infants, as compared to commercially available DTa... bad-data
No trial status on register 2015-005352-10 Immunogenicity and Safety of the Aventis Pasteur DTacP-IPV//PRP~T Combined Vaccine (PENTAXIM™) Given as a Three-Dose Primary Vaccination at 2, 4 and 6 Months of Age and Followed by a Booster Dose at 1... bad-data
No trial status on register 2015-005353-12 Immunogenicity and Safety of the DTacP-IPV//PRP~T Combined Vaccine (PENTAXIM™) Given as a Three-Dose Primary Vaccination at 2, 3 and 4 Months of Age or 3, 4 and 5 Months of Age and followed by a Boost... bad-data
No trial status on register 2015-005354-35 Immunogenicity and Safety of the Aventis Pasteur DTacP-IPV//PRP~T Combined Vaccine (PENTAXIM™), Given as a Three-Dose Primary Vaccination at 6, 10, and 14 Weeks of Age and Followed by a Booster Dose a... bad-data
No trial status on register 2015-005403-87 Immunogenicity and Safety of the sanofi pasteur’s DTacP-IPV Combined Vaccine (TETRAXIM™) given as a booster dose at 4 to 6 years of life in children previously vaccinated with PENTAXIM™ in the study E... bad-data
No trial status on register 2015-005404-29 Safety of the DTacP-IPV//PRP~T Combined Vaccine (PENTAXIM®) Given as a Three-Dose Primary Vaccination at 2, 3, and 4 Months of Age in Infants in China bad-data
No trial status on register 2015-005589-43 Safety and immunogenicity of Tetanus and Diphtheria Toxoids Adsorbed Combined with Component Pertussis (ADACEL™) Vaccine compared to Component Pertussis Vaccine and Diphtheria and Tetanus Toxoids Adso... bad-data
No trial status on register 2015-005590-20 Safety Among Adolescents and Adults of Revaccination with Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (ADACEL®) 4 to 5 Years After a Previous Dose bad-data
No trial status on register 2015-005627-84 A pivotal open label, two-arm, multi-center trial to evaluate the safety and immunogenicity of a single dose of Adacel® vaccine in persons 10 to <11 years of age with the intent to extend the licensur... bad-data
No trial status on register 2015-005628-25 Immunogenicity and Safety of The tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed (SP306) as a Booster in Japanese Adolescents bad-data
No trial status on register 2015-005629-38 Immunogenicity of Adacel® and BOOSTRIX® Vaccines in Adolescents bad-data
Other 2015-005789-42 Randomized, Double-blind, Placebo-controlled, Dose escalation, Study on Safety, Pharmacokinetics and Pharmacodynamics of Lixisenatide in Pediatric Patients with Type 2 Diabetes Mellitus Not Adequately... not-yet-due
No trial status on register 2015-005842-69 Immune Responses in Adults to Revaccination with Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (ADACEL®) 10 Years After a Previous Dose bad-data
No trial status on register 2015-005843-15 One-, Three-, Five-, Eight- and Ten-Year Data on the Long- Term Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (Tdap) in Adults and Adolescents bad-data
No trial status on register 2015-005844-32 One-, Three-, Five- and Ten-Year Data on the Long-Term Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (Tdap) in Adolescents 11–14 Years of Age bad-data
No trial status on register 2015-005845-30 One-, Three-, Five-, and Ten-Year Data on the Long-Term Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (Tdap) in Adults and Adolescents (11-64 yea... bad-data
Other 2016-000301-37 Open label, Two Cohort (with and without Imiglucerase), Multicenter Study to Evaluate Pharmacokinetics, Safety, and Efficacy of Eliglustat in Pediatric Patients with Gaucher Disease Type 1 and Type 3 not-yet-due
Ongoing 2016-000464-42 A Prospective, Open-label, Interventional Phase IIIb Clinical Trial to Investigate the Effectiveness of an Additional Course of Alemtuzumab in Relapsing Remitting Multiple Sclerosis Patients After 2 C... not-yet-due
Ongoing 2016-000629-38 A randomized, double-blind, placebo-controlled parallel arm dose titration study to assess the effects of SAR407899 in patients with microvascular angina and/or persistent stable angina despite angiog... not-yet-due
Ongoing 2016-000657-12 Multicenter, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GZ/SAR402671 in Patients with Early-stage Parkinson's Disease ... not-yet-due
Completed, report not yet due 2016-000749-30 Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Toddlers 12 to 23 Months of Age 2017-10-26 not-yet-due
Other 2016-000942-77 A phase 3 randomized, multicenter, multinational, double-blinded study comparing the efficacy and safety of repeated biweekly infusions of neoGAA (GZ402666) and alglucosidase alfa in treatment-naïve p... not-yet-due
Ongoing 2016-001028-80 Efficacy and safety of SAR156597 in the treatment of diffuse cutaneous Systemic Sclerosis (dcSSc): A randomized, double-blind, placebo-controlled, 24-week, proof of concept study not-yet-due
Listed as ongoing, but also has a completion date 2016-001328-77 A 26-Week Randomized, Double-blind, Placebo-controlled, Dose-ranging Phase 2 Study to Assess the Safety and Efficacy of SAR425899 in Patients with Type 2 Diabetes Mellitus 2017-12-27 bad-data
Other 2016-001607-23 A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in Children 6 to <12 Years of Age with Uncontrolled Persistent Asthma not-yet-due
Ongoing 2016-001800-49 A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin Added to Metformin in Patients with Type 2 Diabetes Mellitus Who ... not-yet-due
Ongoing 2016-001801-17 A 52-week Randomized, Double-blind, Double-dummy, Active and Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin compared to Glimepiride or Place... not-yet-due
Ongoing 2016-001803-22 A 26-week Randomized, Double-blind, Controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin compared to Empagliflozin, and Placebo in Patients with Type 2 Di... not-yet-due
Ongoing 2016-001804-43 A Randomized, Double-blind, Placebo-controlled, Parallel-group, 52-week Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin in Patients with Type 2 Diabetes Who Have Inadequate Glyc... not-yet-due
Other 2016-001962-27 Open-label Phase 2 study evaluating efficacy and safety of SAR566658 treatment in patients with CA6 positive metastatic Triple Negative Breast Cancer not-yet-due
No trial status on register 2016-001963-35 A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents bad-data
No trial status on register 2016-001964-13 Regulatory Post-Marketing Surveillance (PMS) Study for AVAXIM 160U (Hepatitis A Vaccine) bad-data
No trial status on register 2016-002089-29 Immunogenicity and Safety of Sanofi Pasteur's DTaP-IPV-Hep B-PRP-T Combined Vaccine Given at 6, 10, and 14 Weeks of Age in Infants in India Who Previously Received a Dose of Hepatitis B Vaccine at Bir... bad-data
Completed, report not yet due 2016-002739-14 Phase 2, Safety and Efficacy Study of Isatuximab, an Anti-CD38 Monoclonal Antibody, Administered by Intravenous (IV) Infusion in Patients with Relapsed or Refractory T-acute Lymphoblastic Leukemia (T-... 2017-11-14 not-yet-due
Ongoing 2016-002826-35 A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin Added to a Sulfonylurea alone or in combination with Metformin in... not-yet-due
No trial status on register 2016-002873-36 Immunogenicity and Safety of Sanofi Pasteur's DTaP-IPV-Hep B-PRP-T Combined Vaccine at 2, 4, and 6 Months of Age versus Sanofi Pasteur's DTaP-IPV//PRP~T Combined Vaccine at 2, 4, and 6 Months of Age +... bad-data
Ongoing 2016-003097-41 A Phase 3 Randomized, Open-label, Multicenter Study Comparing Isatuximab (SAR650984) in Combination with Pomalidomide and Low-dose Dexamethasone versus Pomalidomide and Low-dose Dexamethasone in Patie... not-yet-due
Ongoing 2016-003100-30 A Multi-center, Open-label, Single-arm, Before and After Switch Study to Evaluate the Efficacy, Safety and Tolerability of Alemtuzumab in Pediatric Patients with Relapsing Remitting Multiple Sclerosis... not-yet-due
No trial status on register 2016-003444-37 Bacillus clausii in the treatment of acute community–acquired diarrhea among Latin American children (cadiLAc) bad-data
Other 2016-003475-21 An Open-label Ascending Dose Cohort Study to Assess the Safety, Pharmacokinetics, and Preliminary Efficacy of NeoGAA (GZ402666) in Patients with Infantile-onset Pompe Disease Treated with Alglucosidas... not-yet-due
Completed, report not yet due 2016-004763-40 Immunogenicity and Safety of Quadrivalent Influenza Vaccine (VaxigripTetra™) in Pregnant Women 2018-06-14 not-yet-due
Ongoing 2016-004889-26 A Randomized, Double-blind, Placebo-controlled, 3-arm, Parallel-group 52-week Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin in Patients with Type 2 Diabetes Mellitus and Moder... not-yet-due
Ongoing 2016-004906-32 A Randomized, Double-blind, Placebo-controlled, 3-arm, Parallel group 52-week Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin in Patients with Type 2 Diabetes Mellitus and Sever... not-yet-due
Ongoing 2017-000091-28 Six-month, Randomized, Open-label, Parallel-group Comparison of SAR341402 to NovoLog®/NovoRapid® in Adult Patients With Diabetes Mellitus Also Using Insulin Glargine, with a 6-month Safety Extension P... not-yet-due
No trial status on register 2017-000230-62 A Phase III study of M071754 - A single-blind study in patients with infantile spasms. bad-data
No trial status on register 2017-000239-15 An open-label, uncontrolled 4-week study to assess the safety, efficacy and pharmacokinetics of Allegra® (dry syrup formulation) bad-data
No trial status on register 2017-000251-74 An open-label, uncontrolled 4-week study to assess the safety, efficacy and pharmacokinetics of Allegra® (dry syrup formulation) bad-data
No trial status on register 2017-000611-17 A Long term study of M071754 - A open-label study in patients with infantile spasms. bad-data
Ongoing 2017-001431-39 A Phase 1/2 study to evaluate safety, pharmacokinetics and efficacy of isatuximab in combination with cemiplimab in patients with relapsed/refractory multiple myeloma not-yet-due
Other 2017-001903-60 A Randomized, Double-Blind, Placebo-Controlled Study Followed by an Open Label Treatment Period to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents with Heterozygous Familial... not-yet-due
Ongoing 2017-001940-37 Randomized, Open Label, Multicenter Study Assessing The Clinical Benefit Of Isatuximab Combined With Carfilzomib (Kyprolis®) And Dexamethasone Versus Carfilzomib With Dexamethasone In Patients With R... not-yet-due
Ongoing 2017-001993-40 Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered as a Booster Dose in Children Vaccinated 3 Years Earlier as Toddlers not-yet-due
No trial status on register 2017-002134-23 Open-label, Interventional, Cohort Study to Evaluate Long-term Safety of Dupilumab in Patients with Moderate to Severe Asthma who Completed the TRAVERSE-LTS12551Clinical Trial bad-data
Ongoing 2017-002238-21 A Phase 3 Randomized, Open-label, Multicenter Study Assessing the Clinical Benefit of Isatuximab (SAR650984) in Combination with Bortezomib (Velcade®), Lenalidomide (Revlimid®) and Dexamethasone versu... not-yet-due
No trial status on register 2017-002297-39 An Open-Label Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents with Homozygous Familial Hypercholesterolemia bad-data
Ongoing 2017-002309-36 A randomized, double-blind, parallel-group, 2-treatment multiple dose study to assess the intestinal, metabolic and cardiovascular effects of an 8 weeks treatment with sotagliflozin QD as compared wit... not-yet-due
Ongoing 2017-002644-32 A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotagliflozin on Cardiovascular and Renal Events in Patients with Type 2 Diabetes, Cardi... not-yet-due
Ongoing 2017-002774-39 An Exploratory, Randomized, Double-blind, Placebo-controlled, Parallel Arm Trial of the Safety and Pharmacodynamic Activity of Sotagliflozin in Hemodynamically Stable Patients with Worsening Heart Fai... not-yet-due
Ongoing 2017-002954-35 A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effect of Efpeglenatide on Cardiovascular Outcomes in Type 2 Diabetes Patients at High Cardiovascular ... not-yet-due
Other 2017-003317-25 One year study to evaluate the long-term safety and tolerability of dupilumab in pediatric patients with asthma who participated in a previous dupilumab asthma clinical study not-yet-due
Ongoing 2017-003510-16 A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effects of Sotagliflozin on Clinical Outcomes in Hemodynamically Stable Patients with Type 2 Diabetes ... not-yet-due
Ongoing 2017-004084-12 Multicenter, Randomized, Double-blind, Placebo-controlled Two Stage Study to Characterize the Efficacy, Safety, Tolerability and Pharmacokinetics of GZ/SAR402671 in Patients at risk of Rapidly Progres... not-yet-due
No trial status on register 2017-004148-39 An open-label, first-in-human, dose escalation study of SAR440234 administered as single agent by intravenous infusion in patients with relapsed or refractory acute myeloid leukemia (R/R AML), B-cell ... bad-data
No trial status on register 2017-004181-10 Immunogenicity and Safety of Sanofi Pasteur’s DTaP IPV HB PRP~T Combined Vaccine Given as a Three-Dose Primary Series at 2, 3, 4 Months of Age and Followed by a Booster Dose Given at 16 to 17 Months o... bad-data
No trial status on register 2018-001468-48 Immune Lot Consistency, Immunogenicity, and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adolescents and Adults Aged 10 to 55 Years bad-data
No trial status on register 2018-001470-18 Immunogenicity and Safety of a Booster Dose of an Investigational Quadrivalent Meningococcal Conjugate Vaccine bad-data
No trial status on register 2018-001471-20 Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age bad-data
No trial status on register 2018-001472-38 Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Other Pediatric Vaccines in Healthy Toddlers bad-data